1,859 results on '"Rupp A"'
Search Results
2. Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritis
- Author
-
Dawn Gourlay, S. Rupp, Paul Freeman, M. R. Jackson, H. C. Schenk, Annette Wessmann, Akos Pakozdy, P. Pazzi, S. K. Halstead, Peter K. Smith, Hugh J. Willison, Ezio Bianchi, Nicolas Granger, Gualtiero Gandini, F. Tirrito, Thomas R Harcourt-Brown, Sofie Bhatti, F. Cozzi, Marco Menchetti, Rodrigo Gutierrez-Quintana, Jacques Penderis, M. Le Chevoir, V. Mortera-Balsa, Angie Rupp, A. Tauro, Mark Lowrie, Josep Brocal, Edward Ives, Andrea Tipold, Holger A. Volk, Maurizio Dondi, L. Martinez-Anton, I. Mateo, Mihai Musteata, M. Deutschland, Clare Rusbridge, Roberto José-López, Z. Whitehead, Halstead S.K., Gourlay D.S., Penderis J., Bianchi E., Dondi M., Wessmann A., Musteata M., Le Chevoir M., Martinez-Anton L., Bhatti S.F.M., Volk H., Mateo I., Tipold A., Ives E., Pakozdy A., Gutierrez-Quintana R., Brocal J., Whitehead Z., Granger N., Pazzi P., Harcourt-Brown T., Jose-Lopez R., Rupp S., Schenk H.C., Smith P., Gandini G., Menchetti M., Mortera-Balsa V., Rusbridge C., Tauro A., Cozzi F., Deutschland M., Tirrito F., Freeman P., Lowrie M., Jackson M.R., Willison H.J., and Rupp A.
- Subjects
Male ,medicine.medical_specialty ,Polyradiculoneuropathy ,G(M2) Ganglioside ,Pilot Projects ,Dog, canine, Polyradiculoneuritis ,Gastroenterology ,Immunoglobulin G ,Canine polyradiculoneuritis ,GalNAc-GD1a ,Dogs ,Internal medicine ,medicine ,Animals ,Humans ,Clinical significance ,Dog Diseases ,Small Animals ,biology ,business.industry ,Odds ratio ,Confidence interval ,carbohydrates (lipids) ,Cohort ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Female ,Antibody ,business ,Biomarkers - Abstract
Objectives: \ud A previous single-country pilot study indicated serum anti-GM2 and anti-GA1 anti-glycolipid antibodies as potential biomarkers for acute canine polyradiculoneuritis. This study aims to validate these findings in a large geographically heterogenous cohort.\ud \ud Materials and Methods: \ud Sera from 175 dogs clinically diagnosed with acute canine polyradiculoneuritis, 112 dogs with other peripheral nerve, cranial nerve or neuromuscular disorders and 226 neurologically normal dogs were screened for anti-glycolipid antibodies against 11 common glycolipid targets to determine the immunoglobulin G anti-glycolipid antibodies with the highest combined sensitivity and specificity for acute canine polyradiculoneuritis.\ud \ud Results: \ud Anti-GM2 anti-glycolipid antibodies reached the highest combined sensitivity and specificity (sensitivity: 65.1%, 95% confidence interval 57.6 to 72.2%; specificity: 90.2%, 95% confidence interval 83.1 to 95.0%), followed by anti-GalNAc-GD1a anti-glycolipid antibodies (sensitivity: 61.7%, 95% confidence interval 54.1 to 68.9%; specificity: 89.3%, 95% confidence interval 82.0 to 94.3%) and these anti-glycolipid antibodies were frequently present concomitantly. Anti-GA1 anti-glycolipid antibodies were detected in both acute canine polyradiculoneuritis and control animals. Both for anti-GM2 and anti-GalNAc-GD1a anti-glycolipid antibodies, sex was found a significantly associated factor with a female to male odds ratio of 2.55 (P=0.0096) and 3.00 (P=0.0198), respectively. Anti-GalNAc-GD1a anti-glycolipid antibodies were more commonly observed in dogs unable to walk (odds ratio 4.56; P=0.0076).\ud \ud Clinical Significance: \ud Anti-GM2 and anti-GalNAc-GD1a immunoglobulin G anti-glycolipid antibodies represent serum biomarkers for acute canine polyradiculoneuritis.
- Published
- 2021
3. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery
- Author
-
Saeed Shafiei, Elias Khajeh, Christian Rupp, Sepehr Abbasi, Pegah Eslami, Omid Ghamarnejad, Ali Ramouz, Christoph Springfeld, Sadeq Ali-Hasan-Al-Saegh, Seyed Mostafa Mousavizadeh, Arianeb Mehrabi, Pascal Probst, Carlos Carvalho, and Arash Dooghaie Moghadam
- Subjects
Liver surgery ,medicine.medical_specialty ,Cancer Research ,Carcinoma, Hepatocellular ,Hepatocellular carcinoma ,medicine.medical_treatment ,Urology ,Disease-Free Survival ,medicine ,Genetics ,Odds Ratio ,Hepatectomy ,Humans ,Postoperative Period ,Reduction (orthopedic surgery) ,RC254-282 ,Proportional Hazards Models ,Retrospective Studies ,Liver transplantation ,Liver resection ,business.industry ,Research ,Liver Neoplasms ,Statins ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Statin treatment ,medicine.disease ,Meta-analysis ,Treatment Outcome ,Oncology ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Neoplasm Recurrence, Local ,business - Abstract
Background Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery. Methods PubMed, Web of Science, EMBASE and Cochrane Central were searched. The Outcome of interest was the HCC recurrence after hepatic surgery. Pooled estimates were represented as hazard ratios (HRs) and odds ratios (ORs) using a random-effects model. Summary effect measures are presented together with their corresponding 95% confidence intervals (CI). The certainty of evidence was evaluated using the Grades of Research, Assessment, Development and Evaluation (GRADE) approach. Results The literature search retrieved 1362 studies excluding duplicates. Nine retrospective studies including 44,219 patients (2243 in the statin group and 41,976 in the non-statin group) were included in the qualitative analysis. Patients who received statins had a lower rate of recurrence after liver surgery (HR: 0.53; 95% CI: 0.44–0.63; p P P P Conclusion Statins increase the disease-free survival of patients with HCC after liver surgery. These drugs seem to have chemoprevention effects that decrease the probability of HCC recurrence after liver transplantation or liver resection.
- Published
- 2022
4. Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis
- Author
-
Charles McSharry, Megan K. L. MacLeod, Rodrigo Gutierrez-Quintana, Emer Curley, Karin Williams, Sandeep K. Chahal, Karen Strathdee, George E. Finney, Evarest Onwubiko, Angie Rupp, Katrina Stevenson, Mark R. Jackson, and Anthony J. Chalmers
- Subjects
Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Context (language use) ,Lung injury ,Bleomycin ,Effective dose (radiation) ,Gastroenterology ,Mice ,chemistry.chemical_compound ,Internal medicine ,Weight Loss ,medicine ,Animals ,Humans ,Radiology, Nuclear Medicine and imaging ,Lung volumes ,Lung ,Pneumonitis ,Radiation ,Radiotherapy ,business.industry ,COVID-19 ,Pneumonia ,respiratory system ,medicine.disease ,respiratory tract diseases ,Mice, Inbred C57BL ,Radiation therapy ,Disease Models, Animal ,Biology Contribution ,medicine.anatomical_structure ,Oncology ,chemistry ,Female ,business - Abstract
Purpose:\ud Low-dose whole lung radiotherapy (LDLR) has been proposed as a treatment for patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection and clinical trials are underway. There is an urgent need for preclinical evidence to justify this approach and inform dose, scheduling and mechanisms of action.\ud \ud Materials and methods:\ud Female C57BL/6 mice were treated with intranasal bleomycin sulphate (7.5 or 11.25 units/kg, day 0), then exposed to whole lung radiation therapy (0.5, 1.0, 1.5 Gy or sham, day 3). Bodyweight was measured daily and lung tissue harvested for histology and flow cytometry on day 10. Computed tomography (CT) lung imaging was performed pre-radiation (day 3) and pre-endpoint (day 10).\ud \ud Results:\ud Bleomycin caused pneumonitis of variable severity which correlated with weight loss. LDLR at 1.0 Gy was associated with a significant increase in the proportion of mice recovering to 98% of initial bodyweight and a proportion of these mice exhibited less severe histopathological lung changes. Mice experiencing moderate initial weight loss were more likely to respond to LDLR than those experiencing severe initial weight loss. Additionally, LDLR (1.0 Gy) significantly reduced bleomycin-induced increases in interstitial macrophages, CD103+ dendritic cells and neutrophil-DC hybrids. Overall, bleomycin-treated mice exhibited significantly higher percentages of non-aerated lung in left than right lungs and LDLR (1.0 Gy) limited further reductions in aerated lung volume in right but not left lungs. LDLR at 0.5 and 1.5 Gy did not improve bodyweight, flow cytometric or radiological readouts of bleomycin-induced pneumonitis.\ud \ud Conclusions:\ud Our data support the concept that LDLR can ameliorate acute inflammatory lung injury, identify 1.0 Gy as the most effective dose and provide evidence that it is more effective in the context of moderate than severe pneumonitis. Mechanistically, LDLR at 1.0 Gy significantly suppressed bleomycin-induced accumulation of pulmonary interstitial macrophages, CD103+ dendritic cells and neutrophil-DC hybrids.
- Published
- 2022
5. Eliminating cumulative sleep debt and sleep satiation
- Author
-
T.L. Rupp
- Subjects
medicine.medical_specialty ,business.industry ,education ,Sleep inertia ,Audiology ,Sleep in non-human animals ,Non-rapid eye movement sleep ,humanities ,Sleep deprivation ,Sleep debt ,Anesthesia ,Time course ,Medicine ,Wakefulness ,medicine.symptom ,business ,health care economics and organizations ,Sleep restriction - Abstract
Sleep debt can accumulate from periods of total or partial nights of sleep loss but is generally conceived of as a build-up of sleep pressure resulting from chronic, partial sleep restriction. Both laboratory and epidemiological studies have been used to characterize the neurobehavioral and physiological consequences of sleep debt. Sleep debt and sleep satiation are intertwined with concepts of sleep need, excess wakefulness, sleep extension, and core and optional sleep. The time course of recovery from sleep debt remains unclear; however, recent studies suggest it may have a relative long time constant.
- Published
- 2023
6. Effect of ground technicity on cardio-respiratory and biomechanical parameters in uphill trail running
- Author
-
Thomas Rupp, François Nicot, Pierre Samozino, Frederic Sabater-Pastor, and Guillaume Y. Millet
- Subjects
Male ,Rating of perceived exertion ,medicine.medical_specialty ,business.industry ,Physical Therapy, Sports Therapy and Rehabilitation ,Cardiorespiratory fitness ,General Medicine ,Oxygen uptake ,Running ,Oxygen ,Oxygen Consumption ,Physical medicine and rehabilitation ,Step frequency ,Heart Rate ,Heart rate ,Exercise Test ,medicine ,Humans ,Orthopedics and Sports Medicine ,Treadmill ,business ,Respiratory minute volume - Abstract
The goal of this study was to analyze the effects of ground technicity on cardio-respiratory and biomechanical responses during uphill running. Ten experienced male trail-runners ran ∼ 10.5 min at racing pace on two trails with different (high and low) a priori technicity levels. These two runs were replicated (same slope, velocity, and distance) indoor on a motor-driven treadmill. Oxygen uptake, minute ventilation (VE), heart rate as well as step frequency and medio-lateral feet accelerations (i.e. objective indices of uneven terrain running patterns adjustments) were continuously measured throughout all sessions. Rating of perceived exertion (RPE) and perceived technicity were assessed at the end of each bout. Oxygen cost of running (O2Cr) (+10.5%; p
- Published
- 2021
7. The value of transcutaneous ultrasound in the diagnosis of tonsillar abscess: A retrospective analysis
- Author
-
Malin Miksch, Konstantinos Mantsopoulos, Heinrich Iro, Maximilian Traxdorf, Matti Sievert, Michael Koch, Miguel Goncalves, R Rupp, and Sarina K. Mueller
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Palatine Tonsil ,Tonsillitis ,Sensitivity and Specificity ,Diagnosis, Differential ,03 medical and health sciences ,0302 clinical medicine ,stomatognathic system ,medicine ,Retrospective analysis ,Humans ,Tonsillar abscess ,Peritonsillar Abscess ,030223 otorhinolaryngology ,Abscess ,Retrospective Studies ,Tonsillectomy ,Ultrasonography ,Analysis of Variance ,business.industry ,Ultrasound ,General Medicine ,medicine.disease ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Tonsil ,Female ,Surgery ,Radiology ,business - Abstract
Objective To identify the appropriate treatment in the tonsillar region's infections, a distinction between tonsillitis with or without abscess formation is essential. Ultrasound proved to be a valuable method in identifying abscess formation in the head and neck region. However, no report described the assessment of the tonsil region. This study aims to determine the feasibility of transcervical ultrasound for abscess visualization in the palatal tonsillar region. Methods Retrospective analysis of 354 patients presenting with clinical suspicion of tonsillar abscess to a tertiary referral center and university hospital. All patients received a transcervical ultrasound to establish a primary diagnosis. The existence of an abscess was confirmed by puncture and incision, or final tonsillectomy. If no abscess could be delineated, non-abscessing tonsillitis was supposed, and conservative primary therapy and closed follow-up examinations were performed. Results After the first diagnostic ultrasound examination, in 257 cases (72.59%), the diagnosis of an abscess could be established, but in 97 cases (27.40%), due to missing abscess formation criteria, non-abscessing tonsillitis was documented. Overall, ultrasonography demonstrated an overall accuracy of 78.8% in this selected cohort. The sensitivity, specificity, PPV, and NPV after the first ultrasound examination were calculated with 75.1%, 88.6%, 94.6%, and 57.3%, respectively. Conclusion The presented data confirm that an abscess formation due to tonsillitis can be detected by transcervical ultrasound, enabling prompt, adequate management. As transcervical ultrasound can be conducted fast and is not associated with radiation, it can be regarded as a first-line diagnostic tool in this condition.
- Published
- 2021
8. Letter in response to article in journal of infection: 'The microbiology of chronic osteomyelitis: Changes over ten years'
- Author
-
Florian Hitzenbichler, Susanne Baertl, Nike Walter, Martin Ehrenschwender, Markus Rupp, Ulrike Engelstaedter, and Volker Alt
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Infectious Diseases ,Chronic osteomyelitis ,business.industry ,Humans ,Medicine ,Osteomyelitis ,business ,Dermatology ,Anti-Bacterial Agents - Published
- 2021
9. Prevention of Central-Line Associated Bloodstream Infections
- Author
-
Laura M. Selby, Kelly Cawcutt, and Mark E. Rupp
- Subjects
Microbiology (medical) ,Central line ,medicine.medical_specialty ,Standard of care ,Coronavirus disease 2019 (COVID-19) ,business.industry ,medicine.disease ,Infectious Diseases ,Bacteremia ,Intravascular catheter ,Health care ,Pandemic ,medicine ,business ,Intensive care medicine ,Catheter placement - Abstract
Despite a large volume of research in prevention, central line-associated bloodstream infections and catheter-related bloodstream infections continue to cause significant morbidity, mortality, and increased health care costs. Strategies in prevention, including decision about catheter placement, insertion bundles, adherence to standard of care guidelines, and technologic innovations, shown to decrease rates of catheter-related bloodstream infections and central line-associated bloodstream infections are described in this update. The coronavirus disease 2019 pandemic has resulted in increased health care-acquired infections, including central line-associated bloodstream infections.
- Published
- 2021
10. Bericht zur Sitzung der AG Kopf-Hals-Pathologie
- Author
-
Rupp, Niels, University of Zurich, and Rupp, Niels
- Subjects
2734 Pathology and Forensic Medicine ,German ,medicine.medical_specialty ,business.industry ,10049 Institute of Pathology and Molecular Pathology ,General surgery ,medicine ,language ,610 Medicine & health ,business ,Head and neck ,language.human_language ,Pathology and Forensic Medicine - Published
- 2021
11. Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease
- Author
-
Austin B. Rupp, Kirsten Leigh Rupp, Stacy A. Johnson, and Santosh Reddy
- Subjects
COPD ,medicine.medical_specialty ,Respiratory tract infections ,business.industry ,Bacterial pneumonia ,Retrospective cohort study ,030204 cardiovascular system & hematology ,medicine.disease ,Procalcitonin ,03 medical and health sciences ,Indirect costs ,Pneumonia ,0302 clinical medicine ,Heart failure ,Internal medicine ,Emergency Medicine ,Internal Medicine ,medicine ,030212 general & internal medicine ,business - Abstract
Lower respiratory tract infections (LRTIs) due to bacterial pneumonia are common among hospitalized patients and are frequently treated with antibiotics. Viral illnesses and exacerbations of heart failure or COPD may present with symptoms mimicking a LRTI, resulting in unnecessary antibiotic utilization. Procalcitonin testing may be useful in these clinical scenarios. We attempted to assess the utility of procalcitonin testing versus not testing, and positive versus negative results among hospitalized patients with suspected LRTI. We performed a retrospective cohort study using multivariable analysis comparing clinical outcomes of patients with and without procalcitonin testing. Patients were 18 years or older, hospitalized for pneumonia, heart failure, COPD, or a viral respiratory illness between October 2014 and October 2015 (n = 2353). All patients received at least one dose of antibiotics. Major outcomes were duration of antibiotic therapy, length of hospital stay, C. difficile testing and infections, and normalized total direct costs. Procalcitonin testing occurred in 14.0% of patients and pneumonia (70.6%) was the most common diagnosis. After covariate adjustments, mean length of stay (5.61 vs. 6.67 days, p < 0.001) and duration of antibiotics (3.95 vs. 4.47 days, p < 0.001) were shorter among tested patients. Fewer 30-day readmissions (OR 0.62, 95% CI 0.40-0.95) were observed, and total direct healthcare costs were 34% lower (0.66, 95% CI 0.58-0.74) among tested patients. Negative procalcitonin results were associated with further reductions in some outcomes. In conclusion, procalcitonin testing among hospitalized patients with suspected LRTI is associated with reductions in antibiotic duration, length of stay, 30-day readmission, and healthcare costs.
- Published
- 2021
12. Daily Predictors of ART Adherence Among Young Men Living with HIV Who Have Sex with Men: A Longitudinal Daily Diary Study
- Author
-
Betty M Rupp, Matthew A. Psioda, Arlene C. Seña, Kimberly Enders, and Emily M. Cherenack
- Subjects
Male ,medicine.medical_specialty ,Social Psychology ,Substance-Related Disorders ,HIV Infections ,Article ,Medication Adherence ,Sexual and Gender Minorities ,Social support ,Acquired immunodeficiency syndrome (AIDS) ,Humans ,Medicine ,Retrospective Studies ,Recall ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,medicine.disease ,United States ,Sexual minority ,Health psychology ,Infectious Diseases ,Mood ,business ,Psychosocial ,Demography - Abstract
Improving adherence to antiretroviral therapy (ART) is essential for limiting HIV disease progression among young sexual minority men living with HIV. Daily diaries allow for a detailed examination of how fluctuations in psychosocial factors are associated with adherence over time. Across three cities in the United States, this study collected 60 days of quantitative data from 44 young men (between 16 and 24 years of age) living with HIV who have sex with men. Lagged transition models explored the associations of mood, stress, social support, substance use, and condomless intercourse with daily ART adherence. Baseline levels of illicit substance use and condomless intercourse, and a higher proportion of days with stress or marijuana use, were associated with lower ART adherence. Lapses in adherence predicted non-adherence the following day. Findings suggest prospective data collection may identify different predictors of adherence compared to retrospective recall. Lapse-management strategies are needed to improve adherence following a missed dose.
- Published
- 2021
13. Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer
- Author
-
Alexander Maurer, Daniela A. Ferraro, Riccardo Laudicella, Niels J. Rupp, Konstantinos Zeimpekis, Olivio F. Donati, Iliana Mebert, Irene A. Burger, Marcelo Tatit Sapienza, Julian Müller, Daniel Eberli, Hannes Grünig, and Jan H. Rueschoff
- Subjects
medicine.medical_specialty ,PET-CT ,medicine.diagnostic_test ,business.industry ,General Medicine ,urologic and male genital diseases ,medicine.disease ,Lesion ,Prostate cancer ,Biopsy ,medicine ,Immunohistochemistry ,Radiology, Nuclear Medicine and imaging ,Histopathology ,Sampling (medicine) ,medicine.symptom ,Counts per minute ,Nuclear medicine ,business - Abstract
Purpose Prostate-specific membrane antigen (PSMA)-targeted PET is increasingly used for staging prostate cancer (PCa) with high accuracy to detect significant PCa (sigPCa). [68 Ga]PSMA-11 PET/MRI-guided biopsy showed promising results but also persisting limitation of sampling error, due to impaired image fusion. We aimed to assess the possibility of intraoperative quantification of [18F]PSMA-1007 PET/CT uptake in core biopsies as an instant confirmation for accurate lesion sampling. Methods In this IRB-approved, prospective, proof-of-concept study, we included five consecutive patients with suspected PCa. All underwent [18F]PSMA-1007 PET/CT scans followed by immediate PET/CT-guided and saturation template biopsy (3.1 ± 0.3 h after PET). The activity in biopsy cores was measured as counts per minute (cpm) in a gamma spectrometer. Pearson’s test was used to correlate counts with histopathology (WHO/ISUP), tumor length, and membranous PSMA expression on immunohistochemistry (IHC). Results In 43 of 113 needles, PCa was present. The mean cpm was overall significantly higher in needles with PCa (263 ± 396 cpm) compared to needles without PCa (73 ± 44 cpm, p max 8.7), 13 out of 24 needles had increased counts (100–200 cpm) but only signs of inflammation and PSMA expression in benign glands on IHC. Excluding this case, ROC analysis resulted in an AUC of 0.81, with an optimal cut-off to confirm PCa at 75 cpm (sens/spec of 65.1%/87%). In all 4 patients with PCa, the first or second PSMA PET-guided needle was positive for sigPCa with high counts (156–2079 cpm). Conclusions [18F]PSMA-1007 uptake in PCa can be used to confirm accurate lesion sampling of the dominant tumor intraoperatively. This technique could improve confidence in imaging-based biopsy guidance and reduce the need for saturation biopsy. Trial registration number NCT03187990, 15/06/2017.
- Published
- 2021
14. Vertebral osteomyelitis is characterised by increased RANK/OPG and RANKL/OPG expression ratios in vertebral bodies and intervertebral discs
- Author
-
Frank Hanses, Volker Alt, Carsten Neumann, S Grad, M Rupp, J Gläsner, M Simon, S Lang, Markus Loibl, and A Gessner
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Vertebral Body ,RD1-811 ,610 Medizin ,Adipokine ,Context (language use) ,Diseases of the musculoskeletal system ,Bone remodeling ,Pathogenesis ,Osteoprotegerin ,Internal medicine ,medicine ,Vertebral osteomyelitis ,Humans ,spine-vertebral body ,signalling molecules-cytokines ,Intervertebral Disc ,adipokines ,ddc:610 ,biology ,Receptor Activator of Nuclear Factor-kappa B ,business.industry ,RANK Ligand ,vertebral osteomyelitis ,Osteomyelitis ,medicine.disease ,musculoskeletal system ,Endocrinology ,Vertebral osteomyelitis, signalling molecules-cytokines, adipokines, cells/tissues-intervertebral disc, infection-in vivo, spine-vertebral body, osteoimmunity, RANK/RANKL/OPG ,cells/tissues-intervertebral disc ,RC925-935 ,RANKL ,osteoimmunity ,biology.protein ,Resistin ,Surgery ,infection-in vivo ,business - Abstract
Vertebral osteomyelitis (VO) is an infection of the spine mainly caused by bacterial pathogens. The pathogenesis leading to destruction of intervertebral discs (IVDs) and adjacent vertebral bodies (VBs) is poorly described. The present study aimed at investigating the connection between infection and bone/disc metabolism in VO patients. 14 patients with VO (infection group) and 14 patients with burst fractures of the spine (fracture group; control) were included prospectively. Tissue biopsies from affected IVDs and adjacent VBs were analysed by RT-qPCR for mRNA-expression levels of 18 target genes including chemokines, adipokines and genes involved in bone metabolism. Most importantly, the receptor activator of NF-κB/osteoprotegerin (RANK/OPG) expression ratio was drastically elevated in both VBs and IVDs of the infection group. In parallel, expression of genes of the prostaglandin-E2-dependent prostanoid system was induced. Such genes regulate tissue degradation processes via the triad OPG/RANK/RANKL as well as via the chemokines IL-8 and CCL-20, whose expression was also found to be increased upon infection. The gene expression of the adipokine leptin, which promotes inflammatory tissue degradation, was higher in IVD tissue of the infection group, whereas the transcription of omentin and resistin genes, whose functions are largely unknown in the context of infectious diseases, was lower in infected VBs. In summary, similar expression patterns of pro-inflammatory cytokines and pro-osteoclastogenic factors were identified in VBs and IVDs of patients suffering from VO. This suggests that common immuno-metabolic pathways are involved in the mechanisms leading to tissue degradation in VBs and IVDs during VO.
- Published
- 2021
15. Das deutschlandweite, webbasierte ParaReg-Register zur lebenslangen Dokumentation von Querschnittgelähmten – Datenmodell, rechtlich-ethische Voraussetzungen und technische Implementierung
- Author
-
Andreas Badke, Doris Maier, Christian Schuld, Rüdiger Rupp, Nils-Hendrik Benning, Petra Knaup-Gregori, Patrick Jersch, Joachim Schweidler, Andreas Hildesheim, Mirko Aach, Norbert Weidner, and Marion Saur
- Subjects
Gynecology ,medicine.medical_specialty ,Political science ,Public Health, Environmental and Occupational Health ,medicine ,Patient centered - Abstract
Ziel der Studie In Deutschland unterscheiden sich die Behandlungspfade von frisch Querschnittgelähmten in Abhängigkeit von intrinsisch-krankheitsspezifischen und extrinsischen Faktoren erheblich. Welche dieser Faktoren mit einem verbesserten Outcome, weniger Folgekomplikationen und stationären Wiederaufnahmen assoziiert sind, ist bis heute nicht bekannt. Daher soll das deutschlandweite, patientenzentrierte, webbasierte ParaReg-Register implementiert werden, um langfristig eine bessere Qualität der Patientenversorgung, Planung der Behandlungspfade und Kosteneffizienz zu erreichen. Methodik In der Konzeptionierungsphase 2017/18 wurde das Datenmodell des Registers vom ParaReg-Leitungskomitee in einem iterativen Prozess zusammen mit dem erweiterten Vorstand der Deutschsprachigen Medizinischen Gesellschaft für Paraplegiologie e.V. (DMGP) und Patientenvertretern entwickelt. In ParaReg werden soziale und medizinische Routinedaten zusammen mit international etablierten neurologischen, funktionellen und partizipationsbezogenen Scores dokumentiert. Die Vergabe einer eindeutigen Patienten-ID erlaubt lebenslang eine zentrumsübergreifende Dokumentation von stationären Aufenthalten in einem der 27 in Deutschland in der DMGP organisierten Querschnittzentren. Das ParaReg-Datenschutzkonzept und die Patienteninformation/-einwilligung orientieren sich an den um DSGVO-relevante Aspekte erweiterten Vorlagen des Open Source Registers für seltene Erkrankungen (OSSE). Ergebnisse In der 2019 begonnenen Realisierungsphase wurde die informationstechnische Infrastruktur gemäß des klinischen ID-Management-Moduls der Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V. (TMF) umgesetzt. Parallel wurden die rechtlich-ethischen Voraussetzungen für den Registerbetrieb unter der Schirmherrschaft der DMGP geschaffen. In das Datenschutzkonzept sind die Empfehlungen der Arbeitsgruppe Datenschutz der TMF eingeflossen. Basierend auf den Rückmeldungen aus der Alpha-Testphase mit Eingabe der Aufenthaltsdaten von 40 Patienten wurde die Ergonomie der elektronischen Eingabeformulare speziell für mobile Eingabegeräte verbessert. Schlussfolgerung Mit Abschluss der monozentrischen Alpha-Testphase hat die multizentrische Datenerhebung an 5 DMGP-Querschnittzentren begonnen. Die Nachhaltigkeit von ParaReg ist durch die strukturelle und finanzielle Unterstützung durch die DMGP auch nach Auslaufen der Förderung durch das Bundesministerium für Bildung und Forschung (BMBF) gesichert.
- Published
- 2021
16. Key role of left ventricular untwisting in endurance cyclists at onset of exercise
- Author
-
Philippe Obert, Nicolas Tordi, Thomas Rupp, Laurent Mourot, Omar Izem, Antoine Grandperrin, Stéphane Nottin, EA4278 Laboratoire de Pharm-Ecologie Cardiovasculaire (LaPEC), and Avignon Université (AU)
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Physiology ,[SDV]Life Sciences [q-bio] ,Heart Ventricles ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Physiology (medical) ,Internal medicine ,Humans ,Medicine ,Exercise ,Consumption (economics) ,Rest (physics) ,business.industry ,Stroke Volume ,030229 sport sciences ,Echocardiography ,cardiovascular system ,Key (cryptography) ,Cardiology ,business - Abstract
International audience; The rise in oxygen consumption during the transition from rest to exercise is faster in those who are endurance-trained than those who have sedentary lifestyles, partly due to a more efficient cardiac response. However, data regarding this acute cardiac response in trained individuals are limited to heart rate (HR), stroke volume and cardiac output. Considering this, we compared cardiac kinetics, including left ventricular (LV) strains and twist/untwist mechanics, between endurance-trained cyclists and their sedentary counterparts. Twenty young, male, trained cyclists and 23 untrained participants aged 18-25 years performed five similar constant workload exercises on a cyclo-ergometer (target HR: 130 bpm). During each session, LV myocardial diastolic and systolic linear strains, as well as torsional mechanics, were assessed using speckle-tracking echocardiography. Cardiac function was evaluated every 15s during the first minute and every 30s thereafter, until 240s. Stroke volume increased during the first 30-45s in both groups, but to a significantly greater extent in trained cyclists (31% vs 24%). Systolic parameters were similar in both groups. Transmitral peak filling velocity and peak filling rate responded faster to exercise and with greater amplitude in trained cyclists. Left ventricular filling pressure was lower in the former, while LV relaxation was greater, but only at the base of the left ventricle. Basal rotation and peak untwisting rate responded faster and to a greater extent in the cyclists. This study provides new mechanical insights into the key role of LV untwisting in the more efficient acute cardiac response of endurance-trained athletes at onset of exercise.
- Published
- 2021
17. Transient recovery of epicardial and torso ST-segment ischemic signals during cardiac stress tests: A possible physiological mechanism
- Author
-
Jake A. Bergquist, Vikas Sharma, Maura Perez, Lindsay C Rupp, Rob S. MacLeod, Gregory J. Stoddard, Brian Zenger, and Wilson W. Good
- Subjects
Cardiac function curve ,medicine.medical_specialty ,Swine ,Myocardial Ischemia ,Ischemia ,Article ,Electrocardiography ,Internal medicine ,Cardiac conduction ,medicine ,Animals ,ST segment ,medicine.diagnostic_test ,business.industry ,ST elevation ,Torso ,Cardiac stress test ,Heart ,medicine.disease ,medicine.anatomical_structure ,Cardiology ,Dobutamine ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
2.1. BACKGROUND: Acute myocardial ischemia has several characteristic ECG findings, including clinically detectable ST-segment deviations. However, the sensitivity and specificity of diagnosis based on ST-segment changes are low. Furthermore, ST-segment deviations have been shown to be transient and spontaneously recover without any indication the ischemic event has subsided. 2.2. OBJECTIVE: Assess the transient recovery of ST-segment deviations on remote recording electrodes during a partial occlusion cardiac stress test and compare them to intramyocardial ST-segment deviations. 2.3. METHODS: We used a previously validated porcine(BZ) experimental model of acute myocardial ischemia with controllable ischemic load and simultaneous electrical measurements within the heart wall, on the epicardial surface, and on the torso surface. Simulated cardiac stress tests were induced by occluding a coronary artery while simultaneously pacing rapidly or infusing dobutamine to stimulate cardiac function. Postexperimental imaging created anatomical models for data visualization and quantification. Markers of ischemia were identified as deviations in the potentials measured at 40% of the ST-segment. Intramural cardiac conduction speed was also determined using the inverse gradient method. We assessed changes in intramyocardial ischemic volume proportion, conduction speed, clinical presence of ischemia on remote recording arrays, and regional changes to intramyocardial ischemia. We defined the peak deviation response time as the time interval after onset of ischemia at which maximum ST-segment deviation was achieved, and ST-recovery time was the interval when ST deviation returned to below thresholded of ST elevation. 2.4. RESULTS: In both epicardial and torso recordings, the peak ST-segment deviation response time was 4.9 ± 1.1 min and the ST-recovery time was approximately 7.9 ± 2.5min, both well before the termination of the ischemic stress. At peak response time, conduction speed was reduced by 50% and returned to near baseline at ST-recovery. The overall ischemic volume proportion initially increased, on average, to 37% at peak response time; however, it recovered only to 30% at the ST-recovery time. By contrast, the subepicardial region of the myocardial wall showed 40% ischemic volume at peak response time and recovered much more strongly to 25% as epicardial ST-segment deviations returned to baseline. 2.5. CONCLUSION: Our data show that remote ischemic signal recovery correlates with a recovery of the subepicardial myocardium, while subendocardial ischemic development persists.
- Published
- 2021
18. Endoscopic Stent Placement Can Successfully Treat Gastric Leak Following Laparoscopic Sleeve Gastrectomy If and Only If an Esophagoduodenal Megastent Is Used
- Author
-
Beat P. Müller-Stich, Peter Sauer, Anja Schaible, Felix Nickel, Moritz von Frankenberg, Adrian T. Billeter, Christian Rupp, Franck Billmann, Ronald Koschny, and Aylin Pfeiffer
- Subjects
Laparoscopic surgery ,Bariatric surgery ,medicine.medical_specialty ,Laparoscopic sleeve gastrectomy ,Nutrition and Dietetics ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Original Contributions ,Stent ,Gastric leak ,Retrospective cohort study ,Surgery ,Treatment efficacy ,Staple line ,medicine ,Complication ,business ,Gastrectomy, Postoperative complications ,Endoscopic stent - Abstract
Purpose Gastric staple line leakage (GL) is a serious complication of laparoscopic sleeve gastrectomy (LSG), with a specific mortality ranging from 0.2 to 3.7%. The current treatment of choice is stent insertion. However, it is unclear whether the type of stent which is inserted affects treatment outcome. Therefore, we aimed not only to determine the effectiveness of stent treatment for GL but also to specifically clarify whether treatment outcome was dependent on the type of stent (small- (SS) or megastent (MS)) which was used. Patients and Methods A single-centre retrospective study of 23 consecutive patients was conducted to compare the outcomes of SS (n = 12) and MS (n = 11) for the treatment of GL following LSG. The primary outcome measure was the success rate of stenting, defined as complete healing of the GL without changing the treatment strategy. Treatment change or death were both coded as failure. Results The success rate of MS was 91% (10/11) compared to only 50% (6/12) for SS (p = 0.006). An average of 2.3 ± 0.5 and 6.8 ± 3.7 endoscopies were required to achieve healing in the MS and SS groups respectively (p < 0.001). The average time to resumption of oral nutrition was shorter in the MS group (1.4 ± 1.1 days vs. 23.1 ± 33.1 days, p = 0.003). Conclusions Stent therapy is only effective and safe for the treatment of GL after LSG if a MS is used. Treatment with a MS may not only increase treatment success rates but may also facilitate earlier resumption of oral nutrition and shorten the duration of hospitalization. Graphical Abstract
- Published
- 2021
19. <scp>Whole‐body</scp> hybrid positron emission tomography imaging yields clinically relevant information in the staging and restaging of sinonasal tumors
- Author
-
Michael B. Soyka, Niels J. Rupp, Martin W. Huellner, David Holzmann, Michael Messerli, Stephan Skawran, Cäcilia Mader, Hannes Grünig, Lars Husmann, Alexander Maurer, Urs Jakob Mühlematter, and Christian M Meerwein
- Subjects
Paranasal Sinus Neoplasm ,medicine.medical_specialty ,Sensitivity and Specificity ,Fluorodeoxyglucose F18 ,Positron Emission Tomography Computed Tomography ,medicine ,Humans ,Lymph node ,Neoplasm Staging ,medicine.diagnostic_test ,business.industry ,Neoplasms, Second Primary ,Magnetic resonance imaging ,Sinonasal Tract ,medicine.disease ,Magnetic Resonance Imaging ,Primary tumor ,medicine.anatomical_structure ,Otorhinolaryngology ,Positron emission tomography ,Positron-Emission Tomography ,Radiological weapon ,Radiology ,Radiopharmaceuticals ,business ,Relevant information - Abstract
BACKGROUND Whole-body hybrid positron emission tomography (PET) imaging is increasingly used for sinonasal tumors. However, only empirical data exist on the additional, clinically relevant information derived from these techniques. METHODS This study included 96 regionalized magnetic resonance imaging (MRI) of the sinonasal tract/neck and separate hybrid FDG-PET/CT or FDG-PET/MRI in 74 patients. Additional radiological information (ARI) obtained from each hybrid examination was analyzed and its clinically relevance was determined. Clinically relevant information (CRI) was categorized with regard to primary tumor site, regional lymph node metastases, distant metastases, second primary tumors, and non-neoplastic findings. RESULTS A total of 45/96 (46.9%) hybrid PET examinations revealed ARI. CRI was found in 32/96 (33.3%) examinations and concerned the primary tumor site (6.1%), regional lymph node metastases (4.1%), distant metastases (14.3%), second primary tumors (7.3%), and non-neoplastic findings (5.1%). CONCLUSIONS Hybrid PET imaging yields additional radiological information translating into clinically relevant information in a substantial proportion of patients with sinonasal tumors.
- Published
- 2021
20. Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA
- Author
-
Stuart C. Gordon, Joseph A. Boscarino, Jennifer Vincent, Jia Li, Keith D. Lindor, Robert J. Romanelli, Sheri Trudeau, Fold Investigators, Jeffrey J. VanWormer, Christopher L. Bowlus, Amandeep Sahota, Heather Anderson, Yihe G. Daida, Carla Rodriguez-Watson, Loralee B Rupp, Christina Melkonian, Kuan-Han Hank Wu, Yueren Zhou, Mei Lu, Mark A Schmidt, and Irina V. Haller
- Subjects
medicine.medical_specialty ,Treatment response ,Physiology ,business.industry ,Gastroenterology ,Hepatology ,medicine.disease ,Ursodeoxycholic acid ,Liver disease ,Primary biliary cirrhosis ,Internal medicine ,Cohort ,medicine ,Pacific islanders ,Risk factor ,business ,medicine.drug - Abstract
Ursodeoxycholic acid (UDCA) remains the first-line therapy for primary biliary cholangitis (PBC); however, inadequate treatment response (ITR) is common. The UK-PBC Consortium developed the modified UDCA Response Score (m-URS) to predict ITR (using alkaline phosphatase [ALP] > 1.67 times the upper limit of normal [*ULN]) at 12 months post-UDCA initiation). Using data from the US-based Fibrotic Liver Disease Consortium, we assessed the m-URS in our multi-racial cohort. We then used a dynamic modeling approach to improve prediction accuracy. Using data collected at the time of UDCA initiation, we assessed the m-URS using the original formula; then, by calibrating coefficients to our data, we also assessed whether it remained accurate when using Paris II criteria for ITR. Next, we developed and validated a dynamic risk prediction model that included post-UDCA initiation laboratory data. Among 1578 patients (13% men; 8% African American, 9% Asian American/American Indian/Pacific Islander; 25% Hispanic), the rate of ITR was 27% using ALP > 1.67*ULN and 45% using Paris II criteria. M-URS accuracy was “very good” (AUROC = 0.87, sensitivity = 0.62, and specificity = 0.82) for ALP > 1.67*ULN and “moderate” (AUROC = 0.74, sensitivity = 0.57, and specificity = 0.70) for Paris II. Our dynamic model significantly improved accuracy for both definitions of ITR (ALP > 1.67*ULN: AUROC = 0.91; Paris II: AUROC = 0.81); specificity approached 100%. Roughly 9% of patients in our cohort were at the highest risk of ITR. Early identification of patients who will not respond to UDCA treatment using a dynamic prediction model based on longitudinal, repeated risk factor measurements may facilitate earlier introduction of adjuvant treatment.
- Published
- 2021
21. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
- Author
-
Di Pasquale, Marta Francesca, Sotgiu, Giovanni, Gramegna, Andrea, Radovanovic, Dejan, Terraneo, Silvia, Reyes, Luis F, Rupp, Jan, González del Castillo, Juan, Blasi, Francesco, Aliberti, Stefano, Restrepo, Marcos I, Aruj, Patricia Karina, Attorri, Silvia, Barimboim, Enrique, Caeiro, Juan Pablo, Garzón, María I, Cambursano, Victor Hugo, Cazaux, A, Ceccato, Adrian, Chertcoff, Julio, Lascar, Florencia, Tulio, Fernando Di, Díaz, Ariel Cordon, de Vedia, Lautaro, Ganaha, Maria Cristina, Lambert, Sandra, Lopardo, Gustavo, Luna, Carlos M, Malberti, Alessio Gerardo, Morcillo, Nora, Tartara, Silvina, Cetrangolo, Antonio A, Pensotti, Claudia, Pereyra, Betiana, Scapellato, Pablo Gustavo, Stagnaro, Juan Pablo, Shah, Sonali, Lötsch, Felix, Thalhammer, Florian, Anseeuw, Kurt, Francois, Camille A, Van Braeckel, Eva, Vincent, Jean Louis, Djimon, Marcel Zannou, Bashi, Jules, Dodo, Roger, Nouér, Simone Aranha, Chipev, Peter, Encheva, Milena, Miteva, Darina, Petkova, Diana, Balkissou, Adamou Dodo, Yone, Eric Walter Pefura, Ngahane, Bertrand Hugo Mbatchou, Shen, Ning, Xu, Jin-fu, Rico, Carlos Andres Bustamante, Buitrago, Ricardo, Paternina, Fernando Jose Pereira, Ntumba, Jean-Marie Kayembe, Carevic, Vesna Vladic, Jakopovic, Marko, Jankovic, Mateja, Matkovic, Zinka, Mitrecic, Ivan, Jacobsson, Marie-Laure Bouchy, Christensen, Anette Bro, Bødtger, Uffe Christian Heitmann, Meyer, Christian Niels, Jensen, Andreas Vestergaard, Baunbæk-Knudsen, Gertrud, Petersen, Pelle Trier, Andersen, Stine, El-Wahhab, Ibrahim El-Said Abd, Morsy, Nesreen Elsayed, Shafiek, Hanaa, Sobh, Eman, Abdulsemed, Kedir Abdella, Bertrand, Fabrice, Brun-Buisson, Christian, de Montmollin, Etienne, Fartoukh, Muriel, Messika, Jonathan, Tattevin, Pierre, Khoury, Abdo, Ebruke, Bernard, Dreher, Michael, Kolditz, Martin, Meisinger, Matthias, Niederlausitz, Klinikum, Pletz, Mathias W, Hagel, Stefan, Schaberg, Tom, Spielmanns, Marc, Creutz, Petra, Suttorp, Norton, Siaw-Lartey, Beatrice, Dimakou, Katerina, Papapetrou, Dimosthenis, Tsigou, Evdoxia, Ampazis, Dimitrios, Kaimakamis, Evangelos, Bhatia, Mohit, Dhar, Raja, D’Souza, George, Garg, Rajiv, Koul, Parvaiz A, Mahesh, P A, Jayaraj, B S, Narayan, Kiran Vishnu, Udnur, Hirennappa B, Krishnamurthy, Shashi Bhaskara, Kant, Surya, Swarnakar, Rajesh, Limaye, Sneha, Salvi, Sundeep, Golshani, Keihan, Keatings, Vera M, Martin-Loeches, Ignacio, Maor, Yasmin, Strahilevitz, Jacob, Battaglia, Salvatore, Carrabba, Maria, Ceriana, Piero, Confalonieri, Marco, Monforte, Antonella d’Arminio, Prato, Bruno Del, Rosa, Marino De, Fantini, Riccardo, Fiorentino, Giuseppe, Gammino, Maria Antonia, Menzella, Francesco, Milani, Giuseppe, Nava, Stefano, Palmiero, Gerardo, Petrino, Roberta, Gabrielli, Barbra, Rossi, Paolo, Sorino, Claudio, Steinhilber, Gundi, Zanforlin, Alessandro, Franzetti, Fabio, Carugati, Manuela, Morosi, Manuela, Monge, Elisa, Carone, Mauro, Patella, Vincenzo, Scarlata, Simone, Comel, Andrea, Kurahashi, Kiyoyasu, Bacha, Zeina Aoun, Ugalde, Daniel Barajas, Zuñiga, Omar Ceballos, Villegas, José F, Medenica, Milic, van de Garde, E M W, Mihsra, Deebya Raj, Shrestha, Poojan, Ridgeon, Elliott, Awokola, Babatunde Ishola, Nwankwo, Ogonna N O, Olufunlola, Adefuye Bolanle, Olumide, Segaolu, Ukwaja, Kingsley N, Irfan, Muhammad, Minarowski, Lukasz, Szymon, Skoczyński, Froes, Felipe, Leuschner, Pedro, Meireles, Mariana, Ferrão, Cláudia, Neves, João, Ravara, Sofia B, Brocovschii, Victoria, Ion, Chesov, Rusu, Doina, Toma, Cristina, Chirita, Daniela, Dorobat, Carmen Mihaela, Birkun, Alexei, Kaluzhenina, Anna, Almotairi, Abdullah, Bukhary, Zakeya Abdulbaqi Ali, Edathodu, Jameela, Fathy, Amal, Enani, Abdullah Mushira Abdulaziz, Mohamed, Nazik Eltayeb, Memon, Jawed Ulhadi, Bella, Abdelhaleem, Bogdanović, Nada, Milenkovic, Branislava, Pesut, Dragica, Borderìas, Luis, Garcia, Noel Manuel Bordon, Alarcón, Hugo Cabello, Cilloniz, Catia, Torres, Antoni, Diaz-Brito, Vicens, Casas, Xavier, González, Alicia Encabo, Fernández-Almira, Maria Luisa, Gallego, Miguel, Gaspar-GarcÍa, Inmaculada, del Castillo, Juan González, Victoria, Patricia Javaloyes, Martínez, Elena Laserna, de Molina, Rosa Malo, Marcos, Pedro J, Menéndez, Rosario, Pando-Sandoval, Ana, Aymerich, Cristina Prat, de la Torre, Alicia Lacoma, García-Olivé, Ignasi, Rello, Jordi, Moyano, Silvia, Sanz, Francisco, Sibila, Oriol, Rodrigo-Troyano, Ana, Solé-Violán, Jordi, Uranga, Ane, van Boven, Job F M, Torra, Ester Vendrell, Pujol, Jordi Almirall, Feldman, Charles, Yum, Ho Kee, Fiogbe, Arnauld Attannon, Yangui, Ferdaous, Bilaceroglu, Semra, Dalar, Levent, Yilmaz, Ufuk, Bogomolov, Artemii, Elahi, Naheed, Dhasmana, Devesh J, Feneley, Andrew, Ions, Rhiannon, Skeemer, Julie, Woltmann, Gerrit, Hancock, Carole, Hill, Adam T, Rudran, Banu, Ruiz-Buitrago, Silvia, Campbell, Marion, Whitaker, Paul, Youzguin, Alexander, Singanayagam, Anika, Allen, Karen S, Brito, Veronica, Dietz, Jessica, Dysart, Claire E, Kellie, Susan M, Franco-Sadud, Ricardo A, Meier, Garnet, Gaga, Mina, Holland, Thomas L, Bergin, Stephen P, Kheir, Fayez, Landmeier, Mark, Lois, Manuel, Nair, Girish B, Patel, Hemali, Reyes, Katherine, Rodriguez-Cintron, William, Saito, Shigeki, Soni, Nilam J, Noda, Julio, Hinojosa, Cecilia I, Levine, Stephanie M, Angel, Luis F, Anzueto, Antonio, Whitlow, K Scott, Hipskind, John, Sukhija, Kunal, Totten, Vicken, Wunderink, Richard G, Shah, Ray D, Mateyo, Kondwelani John, Noriega, Lorena, Alvarado, Ezequiel, Aman, Mohamed, Labra, Lucía, Value, Affordability and Sustainability (VALUE), Groningen Research Institute for Asthma and COPD (GRIAC), Di Pasquale, M. F., Sotgiu, G., Gramegna, A., Radovanovic, D., Terraneo, S., Reyes, L. F., Rupp, J., Gonzalez Del Castillo, J., Blasi, F., Aliberti, S., Restrepo, M. I., Aruj, P. K., Attorri, S., Barimboim, E., Caeiro, J. P., Garzon, M. I., Cambursano, V. H., Cazaux, A., Ceccato, A., Chertcoff, J., Lascar, F., Tulio, F. D., Diaz, A. C., de Vedia, L., Ganaha, M. C., Lambert, S., Lopardo, G., Luna, C. M., Malberti, A. G., Morcillo, N., Tartara, S., Cetrangolo, A. A., Pensotti, C., Pereyra, B., Scapellato, P. G., Stagnaro, J. P., Shah, S., Lotsch, F., Thalhammer, F., Anseeuw, K., Francois, C. A., Van Braeckel, E., Vincent, J. L., Djimon, M. Z., Bashi, J., Dodo, R., Nouer, S. A., Chipev, P., Encheva, M., Miteva, D., Petkova, D., Balkissou, A. D., Yone, E. W. P., Ngahane, B. H. M., Shen, N., Xu, J. F., Rico, C. A. B., Buitrago, R., Paternina, F. J. P., Ntumba, J. K., Carevic, V. V., Jakopovic, M., Jankovic, M., Matkovic, Z., Mitrecic, I., Jacobsson, M. B., Christensen, A. B., Bodtger, U. C. H., Meyer, C. N., Jensen, A. V., Baunbaek-Knudsen, G., Petersen, P. T., Andersen, S., El-Wahhab, I. E. A., Morsy, N. E., Shafiek, H., Sobh, E., Abdulsemed, K. A., Bertrand, F., Brun-Buisson, C., de Montmollin, E., Fartoukh, M., Messika, J., Tattevin, P., Khoury, A., Ebruke, B., Dreher, M., Kolditz, M., Meisinger, M., Niederlausitz, K., Pletz, M. W., Hagel, S., Schaberg, T., Spielmanns, M., Creutz, P., Suttorp, N., Siaw-Lartey, B., Dimakou, K., Papapetrou, D., Tsigou, E., Ampazis, D., Kaimakamis, E., Bhatia, M., Dhar, R., D'Souza, G., Garg, R., Koul, P. A., Mahesh, P. A., Jayaraj, B. S., Narayan, K. V., Udnur, H. B., Krishnamurthy, S. B., Kant, S., Swarnakar, R., Limaye, S., Salvi, S., Golshani, K., Keatings, V. M., Martin-Loeches, I., Maor, Y., Strahilevitz, J., Battaglia, S., Carrabba, M., Ceriana, P., Confalonieri, M., Monforte, A. D., Prato, B. D., Rosa, M., Fantini, R., Fiorentino, G., Gammino, M. A., Menzella, F., Milani, G., Nava, S., Palmiero, G., Petrino, R., Gabrielli, B., Rossi, P., Sorino, C., Steinhilber, G., Zanforlin, A., Franzetti, F., Carugati, M., Morosi, M., Monge, E., Carone, M., Patella, V., Scarlata, S., Comel, A., Kurahashi, K., Bacha, Z. A., Ugalde, D. B., Zuniga, O. C., Villegas, J. F., Medenica, M., van de Garde, E. M. W., Mihsra, D. R., Shrestha, P., Ridgeon, E., Awokola, B. I., Nwankwo, O. N. O., Olufunlola, A. B., Olumide, S., Ukwaja, K. N., Irfan, M., Minarowski, L., Szymon, S., Froes, F., Leuschner, P., Meireles, M., Ferrao, C., Neves, J., Ravara, S. B., Brocovschii, V., Ion, C., Rusu, D., Toma, C., Chirita, D., Dorobat, C. M., Birkun, A., Kaluzhenina, A., Almotairi, A., Bukhary, Z. A. A., Edathodu, J., Fathy, A., Enani, A. M. A., Mohamed, N. E., Memon, J. U., Bella, A., Bogdanovic, N., Milenkovic, B., Pesut, D., Borderias, L., Garcia, N. M. B., Alarcon, H. C., Cilloniz, C., Torres, A., Diaz-Brito, V., Casas, X., Gonzalez, A. E., Fernandez-Almira, Ml., Gallego, M., Gaspar-GarcIa, I., Victoria, P. J., Martinez, E. L., de Molina, R. M., Marcos, P. J., Menendez, R., Pando-Sandoval, A., Aymerich, C. P., de la Torre, A. L., Garcia-Olive, I., Rello, J., Moyano, S., Sanz, F., Sibila, O., Rodrigo-Troyano, A., Sole-Violan, J., Uranga, A., van Boven, J. F. M., Torra, E. V., Pujol, J. A., Feldman, C., Yum, H. K., Fiogbe, A. A., Yangui, F., Bilaceroglu, S., Dalar, L., Yilmaz, U., Bogomolov, A., Elahi, N., Dhasmana, D. J., Feneley, A., Ions, R., Skeemer, J., Woltmann, G., Hancock, C., Hill, A. T., Rudran, B., Ruiz-Buitrago, S., Campbell, M., Whitaker, P., Youzguin, A., Singanayagam, A., Allen, K. S., Brito, V., Dietz, J., Dysart, C. E., Kellie, S. M., Franco-Sadud, R. A., Meier, G., Gaga, M., Holland, T. L., Bergin, S. P., Kheir, F., Landmeier, M., Lois, M., Nair, G. B., Patel, H., Reyes, K., Rodriguez-Cintron, W., Saito, S., Soni, N. J., Noda, J., Hinojosa, C. I., Levine, S. M., Angel, L. F., Anzueto, A., Whitlow, K. S., Hipskind, J., Sukhija, K., Totten, V., Wunderink, R. G., Shah, R. D., Mateyo, K. J., Noriega, L., Alvarado, E., Aman, M., Labra, L., Di Pasquale M.F., Sotgiu G., Gramegna A., Radovanovic D., Terraneo S., Reyes L.F., Rupp J., Gonzalez Del Castillo J., Blasi F., Aliberti S., Restrepo M.I., Aruj P.K., Attorri S., Barimboim E., Caeiro J.P., Garzon M.I., Cambursano V.H., Cazaux A., Ceccato A., Chertcoff J., Lascar F., Tulio F.D., Diaz A.C., de Vedia L., Ganaha M.C., Lambert S., Lopardo G., Luna C.M., Malberti A.G., Morcillo N., Tartara S., Cetrangolo A.A., Pensotti C., Pereyra B., Scapellato P.G., Stagnaro J.P., Shah S., Lotsch F., Thalhammer F., Anseeuw K., Francois C.A., Van Braeckel E., Vincent J.L., Djimon M.Z., Bashi J., Dodo R., Nouer S.A., Chipev P., Encheva M., Miteva D., Petkova D., Balkissou A.D., Yone E.W.P., Ngahane B.H.M., Shen N., Xu J.F., Rico C.A.B., Buitrago R., Paternina F.J.P., Ntumba J.K., Carevic V.V., Jakopovic M., Jankovic M., Matkovic Z., Mitrecic I., Jacobsson M.B., Christensen A.B., Bodtger U.C.H., Meyer C.N., Jensen A.V., Baunbaek-Knudsen G., Petersen P.T., Andersen S., El-Wahhab I.E.A., Morsy N.E., Shafiek H., Sobh E., Abdulsemed K.A., Bertrand F., Brun-Buisson C., de Montmollin E., Fartoukh M., Messika J., Tattevin P., Khoury A., Ebruke B., Dreher M., Kolditz M., Meisinger M., Niederlausitz K., Pletz M.W., Hagel S., Schaberg T., Spielmanns M., Creutz P., Suttorp N., Siaw-Lartey B., Dimakou K., Papapetrou D., Tsigou E., Ampazis D., Kaimakamis E., Bhatia M., Dhar R., D'Souza G., Garg R., Koul P.A., Mahesh P.A., Jayaraj B.S., Narayan K.V., Udnur H.B., Krishnamurthy S.B., Kant S., Swarnakar R., Limaye S., Salvi S., Golshani K., Keatings V.M., Martin-Loeches I., Maor Y., Strahilevitz J., Battaglia S., Carrabba M., Ceriana P., Confalonieri M., Monforte A.D., Prato B.D., Rosa M., Fantini R., Fiorentino G., Gammino M.A., Menzella F., Milani G., Nava S., Palmiero G., Petrino R., Gabrielli B., Rossi P., Sorino C., Steinhilber G., Zanforlin A., Franzetti F., Carugati M., Morosi M., Monge E., Carone M., Patella V., Scarlata S., Comel A., Kurahashi K., Bacha Z.A., Ugalde D.B., Zuniga O.C., Villegas J.F., Medenica M., van de Garde E.M.W., Mihsra D.R., Shrestha P., Ridgeon E., Awokola B.I., Nwankwo O.N.O., Olufunlola A.B., Olumide S., Ukwaja K.N., Irfan M., Minarowski L., Szymon S., Froes F., Leuschner P., Meireles M., Ferrao C., Neves J., Ravara S.B., Brocovschii V., Ion C., Rusu D., Toma C., Chirita D., Dorobat C.M., Birkun A., Kaluzhenina A., Almotairi A., Bukhary Z.A.A., Edathodu J., Fathy A., Enani A.M.A., Mohamed N.E., Memon J.U., Bella A., Bogdanovic N., Milenkovic B., Pesut D., Borderias L., Garcia N.M.B., Alarcon H.C., Cilloniz C., Torres A., Diaz-Brito V., Casas X., Gonzalez A.E., Fernandez-Almira ML., Gallego M., Gaspar-GarcIa I., Victoria P.J., Martinez E.L., de Molina R.M., Marcos P.J., Menendez R., Pando-Sandoval A., Aymerich C.P., de la Torre A.L., Garcia-Olive I., Rello J., Moyano S., Sanz F., Sibila O., Rodrigo-Troyano A., Sole-Violan J., Uranga A., van Boven J.F.M., Torra E.V., Pujol J.A., Feldman C., Yum H.K., Fiogbe A.A., Yangui F., Bilaceroglu S., Dalar L., Yilmaz U., Bogomolov A., Elahi N., Dhasmana D.J., Feneley A., Ions R., Skeemer J., Woltmann G., Hancock C., Hill A.T., Rudran B., Ruiz-Buitrago S., Campbell M., Whitaker P., Youzguin A., Singanayagam A., Allen K.S., Brito V., Dietz J., Dysart C.E., Kellie S.M., Franco-Sadud R.A., Meier G., Gaga M., Holland T.L., Bergin S.P., Kheir F., Landmeier M., Lois M., Nair G.B., Patel H., Reyes K., Rodriguez-Cintron W., Saito S., Soni N.J., Noda J., Hinojosa C.I., Levine S.M., Angel L.F., Anzueto A., Whitlow K.S., Hipskind J., Sukhija K., Totten V., Wunderink R.G., Shah R.D., Mateyo K.J., Noriega L., Alvarado E., Aman M., and Labra L.
- Subjects
0301 basic medicine ,Male ,Pediatrics ,Etiology ,Multidrug-resistant pathogen ,MRSA ,Pneumocystis pneumonia ,Pneumònia adquirida a la comunitat ,HOSPITALIZED-PATIENTS ,0302 clinical medicine ,Community-acquired pneumonia ,Risk Factors ,Prevalence ,Medicine ,030212 general & internal medicine ,PNEUMOCYSTIS PNEUMONIA ,Articles and Commentaries ,Aged, 80 and over ,Respiratory tract infections ,Anemia, Aplastic ,Middle Aged ,3. Good health ,Community-Acquired Infections ,Europe ,Infectious Diseases ,Immunocompromise ,Microbiology ,Multidrug-resistant pathogens ,Pneumonia ,Etiologia ,Hematologic Neoplasms ,Female ,BLOOD-STREAM INFECTIONS ,Lung Transplantation ,Microbiology (medical) ,medicine.medical_specialty ,Asia ,Neutropenia ,030106 microbiology ,RESPIRATORY-TRACT INFECTIONS ,Settore MED/10 - Malattie Dell'Apparato Respiratorio ,TRANSPLANT RECIPIENTS ,DISEASES-SOCIETY ,03 medical and health sciences ,Immunocompromised Host ,Pneumonia, Bacterial ,MANAGEMENT ,Humans ,pneumonia ,BACTERIAL PNEUMONIA ,Aged ,Acquired Immunodeficiency Syndrome ,business.industry ,microbiology ,Bacterial pneumonia ,Australia ,medicine.disease ,multidrug-resistant pathogens ,Mycoses ,Bacteremia ,Africa ,RISK-FACTORS ,immunocompromise ,Americas ,business - Abstract
Background The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). Conclusions Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.
- Published
- 2019
22. No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020
- Author
-
Panning, Marcus, Wiener, Julius, Dreher, M., Cornelissen, Christian, Knüppel, W., Stolz, D., Suttorp, N., Bauer, W., Mikolajewska, A., Witzenrath, M., Pankow, W., Gläser, S., Rothe, Kathrin, Thiemig, D., Prediger, M., Schmager, S., Kolditz, M., Schulte-Hubbert, B., Langner, S., Rohde, G., Bellinghausen, C., Panning, M., Hoffmann, C., Schneider, Jochen, Welte, T., Freise, J., Barten, G., Kröner, W., Nawrocki, M., Naim, J., Illig, T., Klopp, N., Pletz, M., Kroegel, C., Pletz, Mathias W., Schleenvoigt, B., Forstner, C., Moeser, A., Drömann, D., Parschke, P., Franzen, K., Rupp, J., Käding, N., Wouters, M., Walraven, K., Rohde, Gernot, Braeken, D., Spinner, C., Zaruchas, A., Schaberg, D, Heigener, D., Hering, I., Albrich, W., Waldeck, F., Rassouli, F., Baldesberger, S., Rupp, Jan, Stenger, S., Wallner, M., Burgmann, H., Traby, L., Witzenrath, Martin, Spinner, Christoph D., and Members of the CAPNETZ study group
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Respiratory pathogens ,Epidemiology ,viruses ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,030106 microbiology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Community-acquired pneumonia ,Internal medicine ,Correspondence ,Pandemic ,Medicine ,030212 general & internal medicine ,skin and connective tissue diseases ,Multiplex RT-PCR ,SARS-CoV-2 ,business.industry ,fungi ,General Medicine ,medicine.disease ,respiratory tract diseases ,Community acquired pneumonia ,ddc ,body regions ,Pneumonia ,Infectious Diseases ,Cohort ,Rhinovirus ,business ,Cohort study - Abstract
Purpose The first SARS-CoV-2 cases in Europe were reported in January 2020. Recently, concern arose on unrecognized infections before this date. For a better understanding of the pandemic, we retrospectively analyzed patient samples for SARS-CoV-2 from the prospective CAPNETZ study cohort. Methods We used nasopharyngeal swab samples from a cohort of well characterized patients with community acquired pneumonia of the CAPNETZ study group, recruited from different geographic regions across Germany, Austria, the Netherlands, and Switzerland between 02nd December 2019 and 28th April 2020. Multiplex real-time RT-PCR for a broad range of respiratory pathogens and SARS-CoV-2 real-time RT-PCR were performed on all samples. Results In our cohort, respiratory pathogens other than SARS-CoV-2 were detected in 21.5% (42/195) of patients with rhinovirus as the most frequently detected pathogen. The detection rate increased to 29.7% (58/195) when SARS-CoV-2 was included. No SARS-CoV-2 positive sample was detected before end of March 2020. Conclusions Respiratory viral pathogens accounted for a considerable number of positive results but no SARS-CoV-2 case was identified before the end of March 2020.
- Published
- 2020
23. Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia
- Author
-
N. Klopp, J. Freise, J. Naim, A. Vestergaard-Jensen, H. Buschmann, T. Bauer, M. Wallner, J. Drijkoningen, M. Dreher, A. Mikolajewska, Jan Rupp, Gernot Rohde, Mathias W. Pletz, Santiago Ewig, Martin Witzenrath, S. Langner, M. Witzenrath, Heinz Burgmann, D. Wehde, T. Welte, W. Knüppel, D. Thiemig, P. Ravn, D. Stolz, Christina Forstner, D. Krieger, K. Dalhoff, M. Panning, F. Herth, D. Drömann, J. Rupp, W. Kröner, M. Nawrocki, C. Kroegel, D. Braeken, G. Baunbaek-Knudsen, I. Hering, B. Schulte-Hubbert, S. Schmager, Tobias Welte, Benjamin T. Schleenvoigt, T. Illig, W. Albrich, G. Barten, Martin Kolditz, M. Kreuter, M. Prediger, R. Hörster, O. Arenas Toro, T. Schaberg, G. Rohde, C. Cornelissen, B. Hauptmeier, M. Witte, Norbert Suttorp, P. Creutz, W. Pankow, Vladimir Patchev, M. W. Pletz, S. Hummler, J. Winning, and J. Frosinski
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,biology ,medicine.diagnostic_test ,business.industry ,Mortality rate ,Urinary system ,C-reactive protein ,Critical Care and Intensive Care Medicine ,Logistic regression ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,Community-acquired pneumonia ,Bacteremia ,Internal medicine ,medicine ,biology.protein ,Blood culture ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business ,Cohort study - Abstract
Background Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile. Methods Bacteremia rates were determined in 4,349 patients with CAP enrolled in the multinational cohort study The Competence Network of Community-Acquired Pneumonia (CAPNETZ) and stratified by presence of fever at first patient contact. Independent predictors of bacteremia in patients who were afebrile were determined using logistic regression analysis. Results Bacteremic pneumonia was present in 190 of 2,116 patients who were febrile (8.9%), 101 of 2,149 patients who were afebrile (4.7%), and one of 23 patients with hypothermia (4.3%). Bacteremia rates increased with the CURB-65 score from 3.5% in patients with CURB-65 score of 0 to 17.1% in patients with CURB-65 score of 4. Patients with afebrile bacteremia exhibited the highest 28-day mortality rate (9.9%). Positive pneumococcal urinary antigen test (adjusted OR [AOR], 4.6; 95% CI, 2.6-8.2), C-reactive protein level > 200 mg/L (AOR, 3.1; 95% CI, 1.9-5.2), and BUN level ≥ 30 mg/dL (AOR, 3.1; 95% CI, 1.9-5.3) were independent positive predictors, and antibiotic pretreatment (AOR, 0.3; 95% CI, 0.1-0.6) was an independent negative predictor of bacteremia in patients who were afebrile. Conclusions A relevant proportion of patients with bacteremic CAP was afebrile. These patients had an increased mortality rate compared with patients with febrile bacteremia or nonbacteremic pneumonia. Therefore, the relevance of fever as an indicator for BC necessity merits reconsideration.
- Published
- 2020
24. Charakterisierung der unterschiedlichen Entitäten beim Nierenzellkarzinom
- Author
-
N J Rupp, H Moch, University of Zurich, and Rupp, N J
- Subjects
2748 Urology ,0301 basic medicine ,Gynecology ,medicine.medical_specialty ,Geriatric care ,business.industry ,Urology ,610 Medicine & health ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Renal cell carcinoma ,10049 Institute of Pathology and Molecular Pathology ,030220 oncology & carcinogenesis ,medicine ,business - Abstract
Die Typisierung des Nierenzellkarzinoms (NZK) hat in den letzten Jahren v. a. durch neue molekulare Befunde einen signifikanten Wandel erfahren. Klassische und neu akzeptierte sowie aufkommende Entitaten des NZK werden dargestellt. Eine Literaturrecherche und die Auswertung und Darstellung der Literatur zum Thema verschiedener Entitaten des NZK wurden durchgefuhrt. Die Gruppe der klassischen NZK wie das klarzellige, das papillare und das chromophobe NZK wurden v. a. durch molekulare Techniken um die sog. Translokationskarzinome, die Karzinome mit Alterationen in Genen der mitochondrialen Energiegewinnung sowie potenzielle neue Entitaten erweitert. Die World Health Organization (WHO) hat 2016 neue Tumorentitaten akzeptiert, es wurden aber auch zusatzliche Entitaten vorgeschlagen. Eine prazise Diagnose ist dabei fur die prognostische Einschatzung, potenzielle neue Therapieverfahren sowie mogliche hereditare Assoziationen von groser Bedeutung.
- Published
- 2020
25. What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns
- Author
-
Niels J. Rupp, Irene A. Burger, Riccardo Laudicella, Daniela A. Ferraro, Jan H. Rüschoff, Holger Moch, Thomas Hermanns, Urs J. Muehlematter, Ann-Katrin Rodewald, and Daniel Eberli
- Subjects
Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Prostatectomy ,medicine.medical_treatment ,General Medicine ,urologic and male genital diseases ,medicine.disease ,Prostate cancer ,Positron emission tomography ,Infiltrative Growth Pattern ,Biopsy ,medicine ,Glutamate carboxypeptidase II ,Biomarker (medicine) ,Immunohistochemistry ,Radiology, Nuclear Medicine and imaging ,business - Abstract
Purpose Prostate-specific membrane antigen (PSMA-) PET has become a promising tool in staging and restaging of prostate carcinoma (PCa). However, specific primary tumour features might impact accuracy of PSMA-PET for PCa detection. We investigated histopathological parameters and immunohistochemical PSMA expression patterns on radical prostatectomy (RPE) specimens and correlated them to the corresponding 68Ga-PSMA-11-PET examinations. Methods RPE specimens of 62 patients with preoperative 68Ga-PSMA-11-PET between 2016 and 2018 were analysed. WHO/ISUP grade groups, growth pattern (expansive vs. infiltrative), tumour area and diameter as well as immunohistochemical PSMA heterogeneity, intensity and negative tumour area (PSMA%neg) were correlated with spatially corresponding SUVmax on 68Ga-PSMA-11-PET in a multidisciplinary analysis. Results All tumours showed medium to strong membranous (2–3 +) and weak to strong cytoplasmic (1–3 +) PSMA expression. Heterogeneously expressed PSMA was found in 38 cases (61%). Twenty-five cases (40%) showed at least 5% and up to 80% PSMA%neg. PSMA%neg, infiltrative growth pattern, smaller tumour area and diameter and WHO/ISUP grade group 2 significantly correlated with lower SUVmax values. A ROC curve analysis revealed 20% PSMA%neg as an optimal cutoff with the highest sensitivity and specificity (89% and 86%, AUC 0.923) for a negative PSMA-PET scan. A multiple logistic regression model revealed tumoural PSMA%neg (p p = 0.0497, OR = 306.537) as significant predictors for a negative PSMA-PET scan. Conclusions We describe PSMA%neg, infiltrative growth pattern, smaller tumour size and WHO/ISUP grade group 2 as parameters associated with a lower 68Ga-PSMA-11 uptake in prostate cancer. These findings can serve as fundament for future biopsy-based biomarker development to enable an individualized, tumour-adapted imaging approach.
- Published
- 2021
26. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity
- Author
-
Martin G. Myers, Warren Pan, Ermelinda Ndoka, Wenwen Cheng, Alan C. Rupp, Christopher J. Rhodes, Jessica N. Maung, and David P. Olson
- Subjects
Leptin ,Male ,medicine.medical_specialty ,Science ,Hypothalamus ,General Physics and Astronomy ,Appetite ,Biology ,Neurotransmission ,Neural circuits ,General Biochemistry, Genetics and Molecular Biology ,Article ,Eating ,Mice ,Internal medicine ,Orexigenic ,medicine ,Biological neural network ,Solitary Nucleus ,Animals ,Humans ,Obesity ,Calcitonin receptor ,Neurons ,Prolactin-Releasing Hormone ,Multidisciplinary ,digestive, oral, and skin physiology ,General Chemistry ,respiratory system ,Receptors, Calcitonin ,Diet ,Melanocortins ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Endocrinology ,nervous system ,Female ,Neuron ,Melanocortin ,Energy Metabolism ,medicine.drug ,circulatory and respiratory physiology - Abstract
Calcitonin receptor (Calcr)-expressing neurons of the nucleus tractus solitarius (NTS; CalcrNTS cells) contribute to the long-term control of food intake and body weight. Here, we show that Prlh-expressing NTS (PrlhNTS) neurons represent a subset of CalcrNTS cells and that Prlh expression in these cells restrains body weight gain in the face of high fat diet challenge in mice. To understand the relationship of PrlhNTS cells to hypothalamic feeding circuits, we determined the ability of PrlhNTS-mediated signals to overcome enforced activation of AgRP neurons. We found that PrlhNTS neuron activation and Prlh overexpression in PrlhNTS cells abrogates AgRP neuron-driven hyperphagia and ameliorates the obesity of mice deficient in melanocortin signaling or leptin. Thus, enhancing Prlh-mediated neurotransmission from the NTS dampens hypothalamically-driven hyperphagia and obesity, demonstrating that NTS-mediated signals can override the effects of orexigenic hypothalamic signals on long-term energy balance., Calcitonin receptor-expressing neurons of the nucleus tractus solitarius contribute to long-term control of food intake and body weight. The authors show that a subset of these cells expresses Prlh and that enhancing Prlh-mediated neurotransmission from the NTS dampens hypothalamically-driven hyperphagia and obesity in mice.
- Published
- 2021
27. The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
- Author
-
Gernot Rohde, Mathias W. Pletz, Martin Witzenrath, Theo Dähne, Andreas Essig, Christoph D. Spinner, Marcus Panning, Jan Rupp, Wolfgang Bauer, and Bernhard Schaaf
- Subjects
Adult ,Male ,medicine.medical_specialty ,Letter ,community-acquired pneumonia ,Coronavirus disease 2019 (COVID-19) ,Epidemiology ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,Immunology ,molecular methods ,Microbiology ,Young Adult ,Community-acquired pneumonia ,Virology ,Germany ,Drug Discovery ,Pandemic ,medicine ,Prevalence ,Humans ,In patient ,Prospective Studies ,Respiratory system ,Pandemics ,Respiratory Tract Infections ,Aged ,Bacteria ,business.industry ,SARS-CoV-2 ,COVID-19 ,General Medicine ,Pneumonia ,Middle Aged ,medicine.disease ,Community-Acquired Infections ,Infectious Diseases ,medicine.anatomical_structure ,Emergency medicine ,Viruses ,viral pathogens ,Parasitology ,Female ,business ,Respiratory tract ,prospective study - Abstract
We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subsequent winter seasons remain unclear and support the importance of systematic virological surveillance.
- Published
- 2021
28. Why some parents made firearms more accessible during the beginning of the COVID-19 pandemic: results from a national study
- Author
-
Rebeccah L. Sokol, Rebecca M. Cunningham, Patrick M. Carter, Lea Marineau, Laney Rupp, and Marc A. Zimmerman
- Subjects
Parents ,Firearms ,medicine.medical_specialty ,Adolescent ,Psychological intervention ,Violence prevention ,Article ,SAFER ,Injury prevention ,Pandemic ,medicine ,Humans ,Psychiatry ,Pandemics ,General Psychology ,Harm reduction ,SARS-CoV-2 ,COVID-19 ,Unrest ,United States ,Psychiatry and Mental health ,Health psychology ,Cross-Sectional Studies ,Firearm safety ,Thematic analysis ,Psychology - Abstract
The objective of this study was to assess parents’ firearm storage behaviors during the COVID-19 pandemic and characterize reasons why some parents made their firearms more accessible during this time. In June-July 2020, the study team conducted the FACTS National Survey—a cross-sectional, web-based, survey of 2,924 parents and their teens (ages14–18) regarding firearm-related practices. We weighted descriptive analyses to be nationally representative of parents of teens in the United States. We utilized qualitative thematic analysis to identify parents’ reasons for making firearms more accessible. Five percent of firearm-owning parents of teens reported making their firearms more accessible during the beginning of the COVID-19 pandemic. Reasons why parents increased the ease of firearm access included: (1) Increased civil unrest and riots; (2) Threat of home invasion and/or crime victimization; (3) Fear of panic and the unknown; and (4) Easier access and greater protection, threat unspecified. Some parents—largely motivated by fear—chose to store firearms in a more accessible manner during the beginning of the COVID-19 pandemic to protect their family against possible external threats. Understanding the fear that motivates parents’ decisions regarding storage practices might aid interventions focused on harm reduction and safer storage.
- Published
- 2021
29. Tabakentwöhnung und Verordnung von ambulantem Lungensport im Rahmen der pneumologischen Rehabilitation in Deutschland
- Author
-
Stefan Dewey, Rainer Glöckl, M Limbach, Markus Hayden, Alexander Rupp, and Konrad Schultz
- Subjects
Pulmonary and Respiratory Medicine ,Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,030228 respiratory system ,business.industry ,medicine ,030212 general & internal medicine ,business - Abstract
Zusammenfassung Ziel der Studie Diese Erhebung der Sektion 12 der DGP dient der Erfassung der Angebote der Tabakentwöhnung (TEW) und der Verordnung von Rehabilitationssport (Lungensport) als Reha-Nachsorge im Rahmen der pneumologischen Rehabilitation in Deutschland. Methodik Es erfolgte eine postalische Befragung sämtlicher pneumologischer Rehabilitationskliniken in Deutschland. 67 Kliniken wurden kontaktiert, von denen 62 die Einschlusskriterien erfüllten und 62,9 % die Fragebögen zurücksandten. Ergebnisse Alle Kliniken beurteilen Lungensport als effektive Maßnahme zur Reha-Nachsorge. Jeweils 56,4 % führen hierzu regelmäßig standardisierte Informationsveranstaltungen durch bzw. verteilen entsprechende Informationsbroschüren. 38,5 % der Einrichtungen bieten ambulante Lungensportgruppen an. Der Anteil der Rehabilitanden, die bei Entlassung eine Lungensport-Verordnung erhält, erstreckt sich über das gesamte Spektrum von 0–100 %. Nur jede vierte Klinik gab an, schon einmal von Kostenträgern nach den Ergebnissen der Trainingstherapie gefragt worden zu sein.Sämtliche Kliniken erheben den Rauchstatus der Patienten, zudem werden alle Raucher individuell über die Notwendigkeit einer Tabakabstinenz aufgeklärt. Der Anteil aktiver Raucher wurde auf 33 % geschätzt. In 69,2 % der Kliniken werden regelmäßig standardisierte Vorträge zur TEW durchgeführt, in 61,5 % regelmäßig verhaltenstherapeutische TEW-Gruppentherapien. Zusätzliche Angebote sind bedarfsweise psychologische Beratungen (89,7 %), routinemäßiges Angebot von Nikotinersatzpräparaten (61,5 %) bzw. Vareniclin (15,4 %). Eine Nachsorge wird nur von 10,3 % angeboten. Im Durchschnitt schätzten die Einrichtungen den Anteil an Rauchern, die während der Reha einen Rauchstopp erreichen können, auf 32 %. Seitens der Kostenträger wurde nur eine der Kliniken (2,6 %) schon einmal nach den Ergebnissen der TEW angefragt. Schlussfolgerung Die vorliegende Untersuchung legt nahe, dass viele Rehabilitationskliniken bez. TEW und Verordnung von Lungensport schon einen guten Standard erreicht haben, zeigt aber auch bestehende Verbesserungspotenziale auf. Diese betreffen die Nachsorge bei der TEW sowie die noch nicht durchgängig etablierte Verordnung von Lungensport als Reha-Nachsorge.
- Published
- 2021
30. Prescriber and pharmacist attitudes toward inclusion of diagnosis or clinical indication on prescription orders
- Author
-
Joshua Olsen, Anita C. Murcko, Michael T. Rupp, Courtney Loera, Joseph Murata, Andrew So, and Terri L. Warholak
- Subjects
medicine.medical_specialty ,Attitude of Health Personnel ,Health Personnel ,education ,MEDLINE ,Pharmacist ,Pharmacology (nursing) ,Pharmacy ,Primary care ,Pharmacists ,030226 pharmacology & pharmacy ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Medical prescription ,Pharmacies ,Pharmacology ,business.industry ,Pharmacy education ,Clinical pharmacy ,Prescriptions ,Family medicine ,business ,Inclusion (education) - Abstract
Pharmacy and medication safety organizations have long recommended that diagnosis or clinical indication be required on medication orders to improve the safety and effectiveness of care.To assess attitudes of Arizona prescribers and pharmacists toward the inclusion of the clinical indication or the diagnosis on prescription orders and perceived barriers to its implementation in Arizona.Data were obtained by questionnaires from pharmacists and primary care prescribers after a continuing pharmacy education presentation on the value of including a clinical indication or a diagnosis on prescription orders. The survey was distributed to licensed pharmacists who attended the Arizona Pharmacy Association's Southwest Clinical Pharmacy Seminar. The survey was distributed to primary care providers with active Arizona licenses who attended the Arizona Osteopathic Medical Association Annual Convention and to nurse practitioners after an Arizona Nurse Practitioner Council educational webinar. Prescriber and pharmacist responses were compared using the Mann-Whitney U test. An a priori alpha of 0.05 was used, and in the cases of multiple comparisons, a Bonferroni correction was employed.A total of 74 complete questionnaires were submitted by prescribers and 54 by pharmacists. Approximately 71% of the prescribers and 66% of the pharmacists agreed that they would support voluntary inclusion of a diagnosis or a clinical indication on prescription orders (P = 0.81). However, the 2 groups disagreed on whether the inclusion of the diagnosis or clinical indication should be a requirement (44% of prescribers agreed vs. 96% of pharmacists, P0.001). Two perceived barriers revealed statistically significant differences, with the prescribers being more concerned about possible insurance rejections than pharmacists (P = 0.005, whereas the pharmacists were more concerned about potential software transmission accuracy than prescribers (P0.001).Arizona prescribers and pharmacists in our convenience sample supported the voluntary inclusion of a diagnosis or a clinical indication on prescriptions orders but disagreed as to whether it should be required. Prescribers especially indicated they have a variety of concerns that need to be overcome before they could support a statewide mandate.
- Published
- 2021
31. Long-term patient-related quality of life after successfully treated aseptic non-unions of the long bones
- Author
-
Daniel Popp, Christian Pfeifer, Viola Freigang, Maximilian Kerschbaum, Thilo Hinterberger, Volker Alt, Nike Walter, and Markus Rupp
- Subjects
030222 orthopedics ,medicine.medical_specialty ,business.industry ,Long bone ,030208 emergency & critical care medicine ,Mental health ,Non union ,Fractures, Bone ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Quality of life ,Surveys and Questionnaires ,Quality of Life ,Physical therapy ,Humans ,General Earth and Planetary Sciences ,Normative ,Medicine ,Patient Reported Outcome Measures ,Aseptic processing ,Complication ,business ,Trauma surgery ,General Environmental Science - Abstract
Non-union after fracture depicts a devastating complication in trauma surgery and studies assessing patient-reported outcome measures after stable bone consolidation are rare. Therefore, we aimed to evaluate the long-term impact of aseptic long bone non-union on the patients' physical health state and psychological wellbeing. For this purpose, quality of life after successful surgical treatment of long bone non-union was assessed.Sixty-one patients with aseptic long bone non-union surgically treated in our department between November 2009 and March 2019 with achieved bone consolidation were included. Quality of life was evaluated with the EQ-5D and SF-36 outcome instruments as well as with an ICD-10 based symptom rating (ISR) and compared to normative data.With a minimum follow-up time of one year after the last surgery (mean 4.7 ± 2.7 years) the mean physical health component score of the SF-36 was 38.9 ± 13.7 and the mean mental health component score of the SF-36 was 49.0 ± 5.9, indicating lower quality of life compared to German normative values of 48.4 ± 9.4 (p .001) and 50.9 ± 8.8 (p = 1.61), respectively. The mean EQ-5D index value reached 0.827 ± 0.18 with an EQ-5D VAS rating of 64.4 ± 21.5 compared to scores of 0.922 (p .001) and 72.9 ± 1.1 (p .001) obtained from an age-matched reference population. Mean scores of the ISR did not reveal significant psychological symptom burden in any scale, while an individual analysis showed moderate to severe impairments in 11.5% of the patients in total.Even 4.7 years on average after surgically successful treatment of aseptic long bone non-union, patients still report significant lower quality of life in comparison to normative data. Future clinical studies on non-unions should focus on patient-related outcome measures. Newly emerging treatment strategies and interdisciplinary approaches should be implemented to improve the overall quality of life of non-union patients.
- Published
- 2021
32. Classification challenges of the 2019 revised International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Author
-
Rüdiger Rupp, Mary Schmidt Read, and Steven Kirshblum
- Subjects
030506 rehabilitation ,medicine.medical_specialty ,MEDLINE ,Motor function ,Article ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,medicine ,Humans ,In patient ,Spinal cord injury ,Spinal Cord Injuries ,Retrospective Studies ,Neurologic Examination ,Retrospective review ,business.industry ,American Spinal Injury Association ,General Medicine ,Reference Standards ,Muscle functions ,Spinal cord ,medicine.disease ,medicine.anatomical_structure ,Neurology ,Outcomes research ,Neurology (clinical) ,0305 other medical science ,business ,030217 neurology & neurosurgery - Abstract
Study design Retrospective review of ISNCSCI datasets. Objectives To discuss the correct classification of ISNCSCI datasets considered as challenging. Setting International expert collaboration. Methods The International Standards Committee of the American Spinal Injury Association (ASIA) receives challenging case scenarios regarding the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI). Among those cases received, sample cases representing different categories of typical classification difficulties were identified by members of the International Standards committee. Results From the cases received, five sample cases were identified as representative for publication. These cases are related to the correct classification in the presence of non-SCI related conditions, the determination of motor zones of partial preservation in regions with no myotomes to test, the classification of the ASIA Impairment Scale in patients with substantial motor function below the motor level but no sacral sparing, the inclusion of non-key muscle functions in the classification of sensory incomplete individuals, and the correct classification of individuals with an amputation. Conclusion Presenting cases with challenging classifications, along with responses and explanations, will serve spinal cord injury professionals to better understand and utilize the ISNCSCI classification. As the ISNCSCI endorsed by ASIA and the International Spinal Cord Society (ISCoS) evolves over time, such resources are important to clarify inquiries from the spinal cord injury community and to understand the rationale for revisions.
- Published
- 2021
33. Gender distribution in emergency medicine journals: editorial board memberships in top-ranked academic journals
- Author
-
Aristomenis K. Exadaktylos, Gregor Lindner, Svenja Ravioli, and Adrienne Rupp
- Subjects
medicine.medical_specialty ,Gender diversity ,business.industry ,Significant difference ,Gender distribution ,610 Medicine & health ,Editorial board ,Cross-Sectional Studies ,Obstetrics and gynaecology ,Emergency medicine ,Emergency Medicine ,medicine ,Humans ,Female ,Gender gap ,Periodicals as Topic ,Child ,Citation ,business ,Psychology ,Gender disparity - Abstract
Objective: Despite an established gender gap in academic medicine, evidence on gender diversity in emergency medicine is scarce. In the present study, gender distribution of editorial boards and among editors-in-chief of 31 emergency medicine journals was investigated in 2020/2021 and compared to 2015 and 2010. Additionally, gender distribution in editorial boards of emergency medicine journals was compared to editorial boards in five different medical specialties. Methods: In this cross-sectional analysis, gender of editorial board members and editors-in-chief of journals ranked in the Clarivate Analytics 'Journal Citation Report' (JCR) of 2019 in the sections 'Emergency Medicine', 'Medicine General and Internal', 'Surgery', 'Obstetrics and Gynecology', 'Pediatrics' and 'Orthopedics' were analyzed. Results: In the investigated 31 emergency medicine journals, three out of 35 editors-in-chief (9%) and 299 out of 1810 editorial board members (17%) were women in 2020/2021. In 2015 and 2010, two editors-in-chief were women (13% vs. 15%). In 2015, 19% of editorial board members were women and in 2010 it was 18%, respectively. There was no significant difference in gender distribution among editors-in-chief and editorial board members comparing 2020/2021 with 2015 and 2010 (P = 0.76 vs. P = 0.40, respectively). There was a lower percentage of women in editorial boards of emergency medicine journals compared to the top five JCR-ranked journals in the categories 'Medicine General and Internal', 'Surgery', 'Gynecology and Obstetrics' and 'Pediatrics'. Conclusion: The gender gap in editorial boards and among editors-in-chief of emergency medicine journals seems to be consistent for the last 10 years. Gender disparity appears to be substantial in academic emergency medicine: The percentage of women in emergency medicine editorial boards was lower compared to editorial boards of four other medical specialties.
- Published
- 2021
34. Diagnosing complications following cochlear implantation using transcutaneous ultrasound
- Author
-
R Rupp, Matti Sievert, Joachim Hornung, Heinrich Iro, Ulrich Hoppe, Matthias Balk, Vivian Thimsen, Konstantinos Mantsopoulos, Sarina K. Mueller, and Antoniu-Oreste Gostian
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Single Center ,Cochlear implant ,medicine ,Humans ,ddc:610 ,Retrospective Studies ,Ultrasonography ,Hematoma ,business.industry ,Ultrasound ,Headache ,Reproducibility of Results ,Retrospective cohort study ,General Medicine ,medicine.disease ,Cochlear Implantation ,Cochlear Implants ,Seroma ,Otorhinolaryngology ,Neurosurgery ,Radiology ,Implant ,business - Abstract
Purpose The aim of this study was to investigate the feasibility and reliability of transcutaneous ultrasound for the detection of complications after cochlear implantation. Methods In a single center retrospective cohort study, 115 consecutive cases of suspected complications after cochlear implantation (intervention group) were examined. The rate of pathologic ultrasound findings for specific leading symptoms and diagnoses was compared to a control group comprising twenty consecutive cochlear implants in symptom-free patients. Results Diagnostic ultrasound showed distinctly more pathologic findings in the intervention group (n = 67; 58.3%; p n = 1; 5%). Ultrasound revealed significantly more pathologic findings in haematoma or seroma around the implant (n = 17; 100%; p ϕ = 0.94) and magnet dislocation (n = 44; 97.7%; p ϕ = 0.92) confirmed by a strong effect. Ultrasound examination showed a medium to high effect size in patients presenting with local infections (n = 3; 21.4%; p = 0.283; ϕ = 0.25) and skin flap oedema (n = 2; 50%; p = 0.061; ϕ = 0.51). In contrast, ultrasound examinations displayed a low effect size in undefined cephalgia (0%; p = 0.444; ϕ = 0.17) and device malfunction or failure (0%; p > 0.999; ϕ = 0.13). Conclusion Transcutaneous ultrasound can be advocated as a feasible and effective method in the diagnostic work-up of magnet dislocation and haematoma or seroma around the implant following cochlear implantation. Contrary, ultrasound findings can be expected to be inconspicuous in patients presenting with undefined cephalgia and device malfunction or failure.
- Published
- 2022
35. Infektionen der Wirbelsäule
- Author
-
Carsten Neumann, Markus Rupp, Volker Alt, Frank Hanses, Markus Loibl, and Siegmund Lang
- Subjects
Gynecology ,030222 orthopedics ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Emergency Medicine ,medicine ,030208 emergency & critical care medicine ,Orthopedics and Sports Medicine ,Surgery ,business - Published
- 2021
36. The epidemiology of fracture-related infections in Germany
- Author
-
Siegmund Lang, Volker Alt, Nike Walter, and Markus Rupp
- Subjects
Adult ,Male ,medicine.medical_specialty ,Science ,MEDLINE ,610 Medizin ,Article ,Cohort Studies ,03 medical and health sciences ,Fracture Fixation, Internal ,Fractures, Bone ,Young Adult ,0302 clinical medicine ,Medical research ,Older patients ,Cost of Illness ,Germany ,Health care ,Epidemiology ,Prevalence ,Medicine ,Infection control ,Humans ,Surgical Wound Infection ,030212 general & internal medicine ,Sex Distribution ,Aged ,Aged, 80 and over ,030222 orthopedics ,ddc:610 ,Multidisciplinary ,Trauma Severity Indices ,business.industry ,Gender distribution ,Age Factors ,Middle Aged ,Epidemiological Monitoring ,Treatment strategy ,Female ,Diagnosis code ,business ,Demography - Abstract
The epidemiology of fracture-related infection (FRI) is unknown, which makes it difficult to estimate future demands and evaluate progress in infection prevention. Therefore, we aimed to determine the nationwide burden’s development over the last decade as a function of age group and gender. FRI prevalence as a function of age group and gender was quantified based on annual ICD-10 diagnosis codes from German medical institutions between 2008 through 2018, provided by the Federal Statistical Office of Germany (Destatis). The prevalence of FRI increased by 0.28 from 8.4 cases per 100,000 inhabitants to 10.7 cases per 100,000 inhabitants between 2008 and 2018. The proportion of fractures resulting in FRI increased from 1.05 to 1.23%. Gender distribution was equal. Patients aged 60–69 years and 70–79 years comprised the largest internal proportion with 20.2% and 20.7%, respectively, whereby prevalence increased with age group. A trend towards more diagnoses in older patients was observed with a growth rate of 0.63 for patients older than 90 years. Increasing rates of fracture-related infection especially in older patients indicate an upcoming challenge for stakeholders in health care systems. Newly emerging treatment strategies, prevention methods and interdisciplinary approaches are strongly required.
- Published
- 2021
37. Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention
- Author
-
Betty M Rupp, Aditya H. Gaur, Barbara Heckman, Rachel West Goolsby, Michael G. Hudgens, Melissa Polier, Ini Ubong, Keith J. Horvath, Megan Mueller Johnson, Teresa Filipowicz, K. Rivet Amico, Ronald H. Dallas, Jessica Crawford, and Jane C. Lindsey
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Anti-HIV Agents ,Psychological intervention ,HIV Infections ,Viremia ,Medication Adherence ,Young Adult ,03 medical and health sciences ,Social support ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Humans ,030212 general & internal medicine ,Psychiatry ,Depression (differential diagnoses) ,030505 public health ,business.industry ,Clinical and Epidemiologic Research ,Public Health, Environmental and Occupational Health ,Viral Load ,medicine.disease ,Mental health ,United States ,Clinical trial ,Infectious Diseases ,0305 other medical science ,business ,Viral load - Abstract
A sizable portion of youth (ages 13–24) living with HIV in the United States have unsuppressed viral load. The AIDS Interventions (ATN) 152 study [evaluating the Triggered Escalating Real-Time Adherence (TERA) intervention] baseline data were examined to identify correlates of high viremia (>5000 copies/mL) and self-reported adherence, which can help in planning of differentiated services for viremic youth. Depression, HIV-stigma, and cannabis use were common in this sample of 87 youth. Almost half (48%) had high viremia, which associated with enacted stigma, moderate- to high-risk alcohol use, mental health diagnosis, and age ≥21. Self-reported adherence was related to viral load and associated with mental and physical health functioning, depression, social support, self-confident decision-making, total and internalized stigma, adherence motivation, and report of a missed a care visit in the past 6 months. Mental health emerged as a common correlate of viral load and adherence. Clinical Trial Registration number: NCT03292432.
- Published
- 2021
38. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study
- Author
-
Philip Gath, Christian Rupp, Jan Pfeiffenberger, Arianeb Mehrabi, Shilpa Tiwari-Heckler, Conrad Rauber, Uta Merle, Markus Mieth, and Frederike Lund
- Subjects
Adult ,Male ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,medicine.medical_treatment ,Population ,Disease ,030230 surgery ,Liver transplantation ,Antibodies, Viral ,Article ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,Seroepidemiologic Studies ,Germany ,Internal medicine ,Diabetes mellitus ,Health care ,medicine ,Humans ,Seroprevalence ,Prospective Studies ,Seroconversion ,education ,Prospective cohort study ,Transplantation ,education.field_of_study ,Leukopenia ,SARS-CoV-2 ,business.industry ,COVID-19 ,Middle Aged ,medicine.disease ,Liver Transplantation ,Immunoglobulin G ,Cohort ,RNA, Viral ,Female ,030211 gastroenterology & hepatology ,Surgery ,medicine.symptom ,business - Abstract
Background In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in a large LT recipient cohort. Methods A total of 219 LT recipients were enrolled between May 5, 2020, and August 6, 2020, at the University Hospital Heidelberg. Serum blood samples were collected and tested for anti–SARS-CoV-2 IgG. SARS-CoV-2 RNA was detected in nasopharyngeal swabs using reverse transcription–polymerase chain reaction assays. Results Taking into account known risk factors of arterial hypertension, obesity, diabetes, or leukopenia, LT recipients a priori represented a high-risk cohort for severe COVID-19 with 101 of 219 (46.1%) presenting with more than 2 risk factors for severe COVID-19. Out of 219 LT recipients, 8 (3.7%) either had a positive test result for nasopharyngeal SARS-CoV-2 RNA or anti–SARS-CoV-2 serum IgG. Five of eight (62.5%) did not show any clinical signs of infection, three of eight (37.5%) had self-limited disease, and none required hospitalization for COVID-19. Two of eight (25%) had known exposure to infected health care staff as the probable source of infection. Conclusions In summary, LT recipients showed a SARS-CoV-2 seroconversion rate similar to that of the general population with a substantial percentage of unrecognized infections., Highlights • The seroprevalence of anti-SARS-CoV-2 IgG among liver transplant (LT) recipients in Germany is similar to that in the general population. • The majority of SARS-CoV-2 infections among LT recipients in this study were asymptomatic or mild. • The health-care system might be an important source of SARS-CoV-2 infection in LT recipients.
- Published
- 2021
39. Vergleich der DRG-Erlöse zwischen Fast- und Slow-Track-Verfahren beim zweizeitigen Prothesenwechsel bei periprothetischen Hüftinfektionen im aG-DRG-System 2020
- Author
-
Katja Hierl, Michael Worlicek, Volker Alt, Markus Rupp, Christian Pfeifer, and Florian Baumann
- Subjects
medicine.medical_specialty ,Revisionschirurgie ,Cost-Benefit Analysis ,610 Medizin ,Originalien ,03 medical and health sciences ,Diagnosis Related Group ,0302 clinical medicine ,medicine ,Humans ,Staphylococcal infections ,Orthopedics and Sports Medicine ,030212 general & internal medicine ,Diagnosis-Related Groups ,Gynecology ,030222 orthopedics ,Krankenhaus ,business.industry ,Prostheses and Implants ,Length of Stay ,Hospitals ,Staphylococcus-Infektion ,Diagnosis Related Group, Krankenhaus, Aufenthaltsdauer, Revisionschirurgie, Staphylococcus-Infektion ,Aufenthaltsdauer ,Revision surgery ,business - Abstract
The treatment of periprosthetic hip infections is usually cost intensive, so it is generally not cost effective for hospitals. In chronic infections, a two-stage procedure is often indicated, which can be done as a fast-track procedure with a short prosthetic-free interim interval (2-4 weeks) or as a slow-track procedure with a long prosthetic-free interim interval (over 4 weeks).The aim of this study was to elucidate the revenue situation of both forms of treatment in the aG-DRG-System 2020, taking into account revenue-relevant influencing factors.For fast-track and slow-track procedures with two-stage revision and detection of a staphylococcus aureus (MSSA), treatment cases were simulated using a grouper software (3M KODIP Suite) based on the diagnoses (ICD-10-GM) and procedures (OPS) and then grouped into DRGs. Revenue-relevant parameters, such as length of stay and secondary diagnoses (SD), were taken into account. In addition, two real treatment cases with fast-track and slow-track procedures were compared to each other.The total revenues for the slow-track procedure with a length of stay of 25 days (without SD) were 27,551 € and for a length of stay of 42 days (with SD) even 40,699 €, compared to 23,965 € with the fast-track procedure with a length of stay of 25 days (without SD) and 27,283 € for a length of stay of 42 days (with SD). The real treatment cases also showed a big difference in the total revenues of 12,244 € in favor of the slow-track procedure.Even in the aG-DRG-System 2020, the two-stage revision procedure with a long interim interval seems to be more interesting from a financial point of view and the hospital perspective compared to the fast-track procedure, especially with multimorbid patients. This creates a financial barrier to the treatment of such patients with a short interim interval.HINTERGRUND: Die Behandlung periprothetischer Hüftinfektionen ist meist kostenintensiv und gilt im Allgemeinen als nicht kostendeckend für die Kliniken. Bei chronischen Infektionen ist oft ein zweizeitiger Prothesenwechsel indiziert, der als Fast-Track mit kurzem prothesenfreiem Intervall (2–4 Wochen) oder als Slow-Track mit langem prothesenfreiem Intervall (über 4 Wochen) erfolgen kann. ZIEL: Ziel dieser Arbeit war die Erfassung der Erlössituation beider Behandlungsformen im aktuellen aG-DRG-System 2020 unter Berücksichtigung erlösrelevanter Einflussfaktoren.Für Fast-Track und Slow-Track bei zweizeitigem septischem Hüftprothesenwechsel mit Nachweis eines Staphylococcus aureus (MSSA) wurden mittels einer Grouper-Software (3M KODIP Suite) anhand der Diagnosen (ICD-10-GM) und Prozeduren (OPS) Behandlungsfälle simuliert und in DRG eingruppiert. Erlösrelevante Parameter wie Verweildauer (VWD) und Nebendiagnosen (ND) wurden berücksichtigt. Zusätzlich wurden zwei reale Behandlungsfälle mit Fast-Track und Slow-Track miteinander verglichen.Die Gesamterlöse betrugen beim Slow-Track bei einer VWD von 25 Tagen (ohne ND) 27.551 € und bei einer VWD von 42 Tagen (mit ND) 40.699 €. Beim Fast-Track hingegen lag der Gesamterlös bei 23.965 € bei einer VWD von 25 Tagen (ohne ND) und bei 27.283 € bei einer VWD von 42 Tagen (mit ND). Bei den realen Behandlungsfällen zeigte sich ebenfalls eine deutliche Differenz des Gesamterlöses von 12.244 € zugunsten des Slow-Tracks.Auch im aG-DRG-System 2020 scheint der zweizeitige Hüftprothesenwechsel mit langem Interimsintervall insbesondere bei multimorbiden Patienten aus Krankenhaussicht ökonomisch vorteilhafter zu sein als das Fast-Track-Konzept, wodurch ein finanzielles Hemmnis zur Behandlung solcher Patienten mit kurzem Interimsintervall geschaffen wird.
- Published
- 2021
40. The lack of retropatellar resurfacing at index surgery is significantly associated with failure in patients following patellofemoral inlay arthroplasty: a multi-center study of more than 260 patients
- Author
-
Stephan Vogt, Johannes Holz, Christoph Becher, René Hutter, Matthias J. Feucht, Tim Daniel Rose, Geert Pagenstert, Thilo Patzer, Eva Bartsch, Matthias Cotic, Ulrich Haupt, Jonas Pogorzelski, Stefan Hinterwimmer, Gerrit Bode, Philipp Niemeyer, Thomas Tischer, Turlough O'Donnel, Marco C. Rupp, Andreas B. Imhoff, Theresa Diermeier, Holger Falk, Peter Behrens, René Kaiser, Tobias Knoblauch, Wolfgang Nebelung, and Arne J. Venjakob
- Subjects
medicine.medical_specialty ,WOMAC ,Sports medicine ,Visual analogue scale ,medicine.medical_treatment ,Pain ,Osteoarthritis ,Arthroplasty ,Patellofemoral Joint ,Patient satisfaction ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Retrospective Studies ,business.industry ,Patella ,Perioperative ,Osteoarthritis, Knee ,medicine.disease ,ddc ,Surgery ,Treatment Outcome ,Orthopedic surgery ,business ,Follow-Up Studies - Abstract
Purpose To evaluate the clinical outcomes of patients with a minimum 2-year follow-up following contemporary patellofemoral inlay arthroplasty (PFIA) and to identify potential risk factors for failure in a multi-center study. Methods All patients who underwent implantation of PFIA between 09/2009 and 11/2016 at 11 specialized orthopedic referral centers were enrolled in the study and were evaluated retrospectively at a minimum 2-year follow-up. Clinical outcomes included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, the Knee Injury and Osteoarthritis Outcome Score (KOOS), the Tegner Scale, the visual analogue scale (VAS) for pain, and subjective patient satisfaction. Pre- and perioperative risk factors were compared among failures and non-failures to determine potential risk factors. Results A total of 263 patients (85% follow-up rate) could be enrolled. The mean age at the time of index surgery was 49 ± 12 years with a mean postoperative follow-up of 45 ± 18 months. The overall failure rate was 11% (28 patients), of which 18% (5 patients) were patients with patella resurfacing at index surgery and 82% (23 patients) were patients without initial patella resurfacing. At final follow-up, 93% of the patients who did not fail were satisfied with the procedure with a mean transformed WOMAC Score of 84.5 ± 14.5 points, a mean KOOS Score of 73.3 ± 17.1 points, a mean Tegner Score of 3.4 ± 1.4 points and a mean VAS pain of 2.4 ± 2.0 points. An increased BMI was significantly correlated with a worse postoperative outcome. Concomitant procedures addressing patellofemoral instability or malalignment, the lack of patellofemoral resurfacing at the index surgery and a high BMI were significantly correlated with failure in our patient cohort. Conclusion Patellofemoral inlay arthroplasty shows high patient satisfaction with good functional outcomes at short-term follow-up and thus can be considered a viable treatment option in young patients suffering from isolated patellofemoral arthritis. Patellar resurfacing at index surgery is recommended to decrease the risk of failure. Level of evidence Retrospective case series, Level IV.
- Published
- 2021
41. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade
- Author
-
Dionne C.W. Braeken, Marcus Panning, Martin Witzenrath, Jan Rupp, Mathias W. Pletz, Norbert Suttorp, Andreas Essig, Tobias Welte, M Nawrocki, Klaus Dalhoff, Gernot Rohde, R Hoerster, MUMC+: MA Alg Ond Onderz Longziekten (9), RS: NUTRIM - R3 - Respiratory & Age-related Health, and Pulmonologie
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,IMPACT ,Lung infection ,Culture ,030106 microbiology ,HAEMOPHILUS-INFLUENZAE ,medicine.disease_cause ,Haemophilus influenzae ,03 medical and health sciences ,0302 clinical medicine ,Community-acquired pneumonia ,Internal medicine ,Pneumonia, Bacterial ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Diagnostics ,PATHOGENS ,Bacteria ,business.industry ,Brief Report ,General Medicine ,medicine.disease ,CAP ,Community-Acquired Infections ,Streptococcus pneumoniae ,Infectious Diseases ,Bacterial etiology ,PNEUMOCOCCAL VACCINATION ,Pneumococcal vaccination ,Cohort ,Pulmonary infiltrates ,business - Abstract
To determine the most relevant pathogens for CAP in Germany, patients with radiologically confirmed pulmonary infiltrates and at least one clinical sign of lung infection were prospectively recruited within the CAPNETZ cohort from 2004 until 2016. In 990 out of 4.672 patients (21%) receiving complete diagnostics the most prominent change of pathogens was a decrease of S. pneumoniae (58% in 2004 to 37.5% in 2016; p ≤ 0.001, ρ = − 0.148) and an increase of H. influenzae (12.2% to 20.8%; p = 0.001, ρ = 0.104).
- Published
- 2021
42. Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [18F]FDG PET/CT
- Author
-
Virginia Liberini, Martin W. Huellner, Stephan Skawran, Alexander Maurer, Reinhard Dummer, Niels J. Rupp, Joanna Mangana, Daniela Mihic-Probst, Désirée Deandreis, Ken Kudura, Hannes Grünig, Lars Husmann, Erika Orita, Michael Messerli, Daniele A. Pizzuto, University of Zurich, and Liberini, Virginia
- Subjects
medicine.medical_specialty ,Image Processing ,610 Medicine & health ,Computer-Assisted ,Fluorodeoxyglucose F18 ,Ordered subset expectation maximization ,10049 Institute of Pathology and Molecular Pathology ,Positron Emission Tomography Computed Tomography ,2741 Radiology, Nuclear Medicine and Imaging ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Melanoma ,Retrospective Studies ,Positron Emission Tomography-Computed Tomography ,business.industry ,10177 Dermatology Clinic ,10181 Clinic for Nuclear Medicine ,General Medicine ,Metabolic tumor volume ,Skin neoplasms ,medicine.disease ,Positron Emission Tomography / Computed Tomography ,Algorithms ,Image Processing, Computer-Assisted ,Radiopharmaceuticals ,Radiology Nuclear Medicine and imaging ,Mann–Whitney U test ,Fdg pet ct ,Radiology ,business - Abstract
Objectives To compare block sequential regularized expectation maximization (BSREM) and ordered subset expectation maximization (OSEM) for the detection of in-transit metastasis (ITM) of malignant melanoma in digital [18F]FDG PET/CT. Methods We retrospectively analyzed a cohort of 100 [18F]FDG PET/CT scans of melanoma patients with ITM, performed between May 2017 and January 2020. PET images were reconstructed with both OSEM and BSREM algorithms. SUVmax, target-to-background ratio (TBR), and metabolic tumor volume (MTV) were recorded for each ITM. Differences in PET parameters were analyzed with the Wilcoxon signed-rank test. Differences in image quality for different reconstructions were tested using the Man-Whitney U test. Results BSREM reconstruction led to the detection of 287 ITM (39% more than OSEM). PET parameters of ITM were significantly different between BSREM and OSEM reconstructions (p < 0.001). SUVmax and TBR were higher (76.5% and 77.7%, respectively) and MTV lower (49.5%) on BSREM. ITM missed with OSEM had significantly lower SUVmax (mean 2.03 vs. 3.84) and TBR (mean 1.18 vs. 2.22) and higher MTV (mean 2.92 vs. 1.01) on OSEM compared to BSREM (all p < 0.001). Conclusions BSREM detects significantly more ITM than OSEM, owing to higher SUVmax, higher TBR, and less blurring. BSREM is particularly helpful in small and less avid lesions, which are more often missed with OSEM. Key Points • In melanoma patients, [18F]FDG PET/CT helps to detect in-transit metastases (ITM), and their detection is improved by using BSREM instead of OSEM reconstruction. • BSREM is particularly useful in small lesions.
- Published
- 2021
43. Post-operative septic arthritis after arthroscopy: modern diagnostic and therapeutic concepts
- Author
-
Volker Alt, Peter Angele, Christian Pfeifer, Markus Rupp, Maximilian Kerschbaum, and Andreas Voss
- Subjects
Shoulder ,medicine.medical_specialty ,Sports medicine ,medicine.medical_treatment ,Joint infection · Complication · Arthroscopy · Antibiotics · Shoulder · Knee · Ankle · Hip · Wrist · Elbow ,610 Medizin ,Synovectomy ,Joint infection ,Arthroscopy ,Antibiotics ,Elbow ,Humans ,Medicine ,Knee ,Orthopedics and Sports Medicine ,Rotator cuff ,Therapeutic Irrigation ,ddc:610 ,Arthritis, Infectious ,Hip ,medicine.diagnostic_test ,business.industry ,Wrist ,medicine.disease ,Surgery ,Review article ,Treatment Outcome ,medicine.anatomical_structure ,Debridement ,Orthopedic surgery ,Septic arthritis ,Ankle ,business ,Complication - Abstract
Purpose Septic arthritis is a significant complication following arthroscopic surgery, with an estimated overall incidence of less than 1%. Despite the low incidence, an appropriate diagnostic and therapeutic pathway is required to avoid serious long-term consequences, eradicate the infection, and ensure good treatment outcomes. The aim of this current review article is to summarize evidence-based literature regarding diagnostic and therapeutic options of post-operative septic arthritis after arthroscopy. Methods Through a literature review, up-to-date treatment algorithms and therapies have been identified. Additionally, a supportive new algorithm is proposed for diagnosis and treatment of suspected septic arthritis following arthroscopic intervention. Results A major challenge in diagnostics is the differentiation of the post-operative status between a non-infected hyperinflammatory joint versus septic arthritis, due to clinical symptoms, (e.g., rubor, calor, or tumor) can appear identical. Therefore, joint puncture for microbiological evaluation, especially for fast leukocyte cell-count diagnostics, is advocated. A cell count of more than 20.000 leukocyte/µl with more than 70% of polymorphonuclear cells is the generally accepted threshold for septic arthritis. Conclusion The therapy is based on arthroscopic or open surgical debridement for synovectomy and irrigation of the joint, in combination with an adequate antibiotic therapy for 6–12 weeks. Removal of indwelling hardware, such as interference screws for ACL repair or anchors for rotator cuff repair, is recommended in chronic cases. Level of evidence IV.
- Published
- 2021
44. Protheseninfektionen und die zunehmende Bedeutung psychologischer Komorbiditäten
- Author
-
Thilo Hinterberger, Markus Rupp, Volker Alt, and Nike Walter
- Subjects
Gynecology ,030222 orthopedics ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Medicine ,Orthopedics and Sports Medicine ,030212 general & internal medicine ,business - Abstract
Zusammenfassung Hintergrund Die periprothetische Gelenkinfektion (PJI) ist eine gefürchtete Komplikation in der Orthopädie und Unfallchirurgie. Ein potenzieller Anstieg an PJI-Diagnosen, insbesondere in Verbindung mit psychologischen Komorbiditäten, kann zu einer besonderen Herausforderung für Akteure im Gesundheitswesen werden. Bisher ist die Prävalenz für Deutschland unbekannt. Dies erschwert es, den zukünftigen Behandlungsbedarf abzuschätzen und Entwicklungen vorherzusehen, die durch eine Anpassung von Präventions- und Therapiemaßnahmen beeinflusst werden können. Ziel der Arbeit Die vorliegende Arbeit gibt eine detaillierte Übersicht über die Epidemiologie periprothetischer Gelenkinfektionen und psychologischer Komorbiditäten. Material und Methoden Ein Datensatz vom Statistischen Bundesamt (Destatis) aus jährlichen, deutschlandweiten ICD-10-Diagnosekodes von 2009 bis 2019 wurde analysiert. Prävalenzraten des Kodes „T84.5 – Infektion und entzündliche Reaktion durch eine Gelenkendoprothese“ wurden nach Altersgruppe, Geschlecht und in Verbindung mit einer Nebendiagnose des Kapitels F quantifiziert und aufgeschlüsselt. Ergebnisse Seit 2009 steigen die PJI-Diagnosen kontinuierlich an, die Häufigkeit war im Jahr 2018 rückläufig. Im Jahr 2019 wurden 16.174 Fälle entsprechend einer Prävalenz von 23,8/100.000 Einwohner verzeichnet. Eine Entwicklung hinsichtlich mehr Diagnosen bei älteren Patienten wurde evident. Ein Viertel aller Patienten wiesen eine Nebendiagnosen im Bereich psychischer Störungen und Verhaltensstörungen auf, wobei sich die Anzahl an Patienten mit psychologischen Komorbiditäten im letzten Jahrzehnt verdoppelte. Schlussfolgerung Richtlinien zu Präventionsstrategien und psychologische Unterstützungsangebote sollten in der Unfallchirurgie implementiert werden.
- Published
- 2021
45. Surgical treatment outcome after serial debridement of infected nonunion—A retrospective cohort study
- Author
-
Reinhard Schnettler, Nike Walter, Stefanie Kern, Lydia Anastasopoulou, Christian Heiss, Markus Rupp, and Volker Alt
- Subjects
Reoperation ,medicine.medical_specialty ,medicine.medical_treatment ,Nonunion ,610 Medizin ,Bone Infection ,Medicine ,Humans ,Orthopedics and Sports Medicine ,Infected nonunion ,Prospective Studies ,Prospective cohort study ,Surgical treatment ,Retrospective Studies ,ddc:610 ,Debridement ,business.industry ,Nonunion, Infection, Bone infection, Debridement, Surgery ,Retrospective cohort study ,medicine.disease ,Surgery ,Treatment Outcome ,Amputation ,Fractures, Ununited ,Original Article ,business ,Infection ,Bone infection - Abstract
Purpose Reported outcome after multiple staged surgical treatment of infected nonunion is scarce. We, therefore, asked: (1) What is the clinical outcome in infected nonunion patients after multiple staged revision surgery? (2) Are different pathogens evidenced after surgical treatment in patients who have undergone more or less surgeries? Methods All enrolled patients were surgically treated for long bone-infected nonunion between January 2010 and March 2018. Besides patients´ demographics outcome in terms of bony consolidation and major complications defined as death during inward treatment, amputation and recurrence of infection during follow-up of at least 12 months were assessed. Microbiological findings were assessed and compared between two groups with less than five versus five or more surgical revisions. Results Bone consolidation was achieved in 86% of the patients while complications such as femoral or transtibial amputation, recurrence of infection or even death during inpatient treatment could be evidenced in six patients (14%). In patients who underwent multiple-stage surgery for five or more times, germ changes and repeated germ detection was more common than in patients with less surgeries. Conclusions Surgical treatment of infected nonunions poses a high burden on the patients with major complications occurring in about 14% of the patients using a multiple staged treatment concept. Future prospective studies comparing outcomes after limited with multiple staged revision surgeries are necessary.
- Published
- 2021
46. International Standards for Neurological Classification of Spinal Cord Injury
- Author
-
Linda Jones, Keith E Tansey-Md, Fin Biering-Sørensen, James D. Guest, Mary Schmidt Read, Daniel E. Graves, Stephen P. Burns, Kristen Walden, Gianna M. Rodriguez, Steven Kirshblum, Rüdiger Rupp, and Christian Schuld
- Subjects
medicine.medical_specialty ,Physical medicine and rehabilitation ,Text mining ,business.industry ,Rehabilitation ,medicine ,MEDLINE ,Physical Therapy, Sports Therapy and Rehabilitation ,Neurology (clinical) ,medicine.disease ,business ,Spinal cord injury - Published
- 2021
47. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure
- Author
-
Anne C. Moorman, Mark A Schmidt, Joseph A. Boscarino, Stuart C. Gordon, Eyasu H. Teshale, Loralee B Rupp, Yuna Zhong, Yihe G. Daida, Philip R. Spradling, and Mei Lu
- Subjects
Adult ,Male ,medicine.medical_specialty ,Hepacivirus ,Alcohol use disorder ,Antiviral Agents ,Health Services Accessibility ,White People ,Quality of life (healthcare) ,Health care ,Odds Ratio ,medicine ,Humans ,Healthcare Disparities ,lcsh:RC799-869 ,Psychiatry ,Hepatology ,business.industry ,Original Articles ,Hepatitis C ,Odds ratio ,Middle Aged ,Patient Acceptance of Health Care ,medicine.disease ,Health Surveys ,Comorbidity ,United States ,Black or African American ,Psychosocial Functioning ,Quality of Life ,Anxiety ,Female ,Original Article ,lcsh:Diseases of the digestive system. Gastroenterology ,medicine.symptom ,business ,Psychosocial - Abstract
There are limited data examining the relationship between psychosocial factors and receipt of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care organizations in the United States. We therefore sought to determine whether such factors were associated with DAA initiation. We analyzed data from an extensive psychological, behavioral, and social survey (that incorporated several health‐related quality of life assessments) coupled with clinical data from electronic health records of patients with hepatitis C enrolled at four health care organizations during 2017‐2018. Of 2,681 patients invited, 1,051 (39.2%) responded to the survey; of 894 respondents eligible for analysis, 690 (77.2%) initiated DAAs. Mean follow‐up among respondents was 9.2 years. Compared with DAA recipients, nonrecipients had significantly poorer standardized scores for depression, anxiety, and life‐related stressors as well as poorer scores related to physical and mental function. Lower odds of DAA initiation in multivariable analysis (adjusted by age, race, sex, study site, payment provider, cirrhosis status, comorbidity status, and duration of follow‐up) included Black race (adjusted odds ratio [aOR], 0.59 vs. White race), perceived difficulty getting medical care in the preceding year (aOR, 0.48 vs. no difficulty), recent injection drug use (aOR, 0.11 vs. none), alcohol use disorder (aOR, 0.58 vs. no alcohol use disorder), severe depression (aOR, 0.42 vs. no depression), recent homelessness (aOR, 0.36 vs. no homelessness), and recent incarceration (aOR, 0.34 vs. no incarceration). Conclusion: In addition to racial differences, compared with respondents who initiated DAAs, those who did not were more likely to have several psychological, behavioral, and social impairments. Psychosocial barriers to DAA initiation among patients in care should also be addressed to reduce hepatitis C‐related morbidity and mortality., Even among persons with access to care, receipt of direct‐acting antiviral treatment for hepatitis C is suboptimal. We therefore conducted a detailed psychological, behavioral, and social survey among hepatitis C patients in care to determine whether such factors were associated with DAA initiation. Compared with respondents who initiated DAAs, those who did not were more likely to have several psychological, behavioral, and social impairments, suggesting that such factors should be addressed to reduce hepatitis C‐related morbidity and mortality.
- Published
- 2021
48. High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?
- Author
-
Niels J. Rupp, Gerhard F. Huber, Elisabeth J. Rushing, Sandra N. Freiberger, Constanze Nemes, University of Zurich, and Rupp, Niels J
- Subjects
medicine.medical_specialty ,Pathology ,business.industry ,10208 Institute of Neuropathology ,Morphology (biology) ,610 Medicine & health ,Pathology and Forensic Medicine ,2734 Pathology and Forensic Medicine ,ETV6 ,2733 Otorhinolaryngology ,Oncology ,Otorhinolaryngology ,10049 Institute of Pathology and Molecular Pathology ,medicine ,Oral and maxillofacial surgery ,Salivary Gland Adenocarcinoma ,2730 Oncology ,Letters to the Editor ,business - Published
- 2021
49. PO-1916 Low-dose lung radiotherapy for COVID-19 pneumonia: preclinical studies in bleomycin pneumonitis
- Author
-
E. Onwubiko, A. Rupp, G. Finney, K. Stevenson, Karen Strathdee, M. R. Jackson, C. McSharry, R. Gutierrez-Quintana, Anthony J. Chalmers, E. Curley, S. Chahal, and M. MacLeod
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Lung ,Coronavirus disease 2019 (COVID-19) ,business.industry ,medicine.medical_treatment ,Low dose ,Hematology ,medicine.disease ,Bleomycin ,Gastroenterology ,Radiation therapy ,Pneumonia ,chemistry.chemical_compound ,medicine.anatomical_structure ,Oncology ,chemistry ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,business ,Digital Poster: Implementation of new technology, techniques, clinical protocols or trials (including QA & audit) ,Pneumonitis - Published
- 2021
50. Dislocated hinge fractures are associated with malunion after lateral closing wedge distal femoral osteotomy
- Author
-
Markus Irger, Philipp W. Winkler, Marco-Christopher Rupp, Patricia M. Lutz, Philipp Forkel, Andreas B. Imhoff, and Matthias J. Feucht
- Subjects
Adult ,medicine.medical_specialty ,Medial cortex ,medicine.medical_treatment ,Radiography ,Hinge ,Osteotomy ,Fractures, Bone ,medicine ,Humans ,Orthopedics and Sports Medicine ,Femur ,Malunion ,Closing wedge ,Varus deformity ,Orthodontics ,Tibia ,business.industry ,Middle Aged ,Osteoarthritis, Knee ,medicine.disease ,ddc ,Orthopedic surgery ,Surgery ,business - Abstract
Purpose To evaluate the incidence, morphology, and associated complications of medial cortical hinge fractures after lateral closing wedge distal femoral osteotomy (LCW-DFO) for varus malalignment and to identify constitutional and technical factors predisposing for hinge fracture and consecutive complications. Methods Seventy-nine consecutive patients with a mean age of 47 ± 12 years who underwent LCW-DFO for symptomatic varus malalignment at the authors’ institution between 01/2007 and 03/2018 with a minimum of 2-year postoperative time interval were enrolled in this retrospective observational study. Demographic and surgical data were collected. Measurements evaluating the osteotomy cut (length, wedge height, hinge angle) and the location of the hinge (craniocaudal and mediolateral orientation, relation to the adductor tubercle) were conducted on postoperative anterior–posterior knee radiographs and the incidence and morphology of medial cortical hinge fractures was assessed. A risk factor analysis of constitutional and technical factors predisposing for the incidence of a medial cortical hinge fracture and consecutive complications was conducted. Results The incidence of medial cortical hinge fractures was 48%. The most frequent morphological type was an extension fracture type (68%), followed by a proximal (21%) and distal fracture type (11%). An increased length of the osteotomy in mm (53.1 ± 10.9 vs. 57.7 ± 9.6; p = 0.049), an increased height of the excised wedge in mm (6.5 ± 1.9 vs. 7.9 ± 3; p = 0.040) as well as a hinge location in the medial sector of an established sector grid (p = 0.049) were shown to significantly predispose for the incidence of a medial cortical hinge fracture. The incidence of malunion after hinge fracture (14%) was significantly increased after mediolateral dislocation of the medial cortical bone > 2 mm (p Conclusion Medial cortical hinge fractures after LCW-DFO are a common finding. An increased risk of sustaining a hinge fracture has to be expected with increasing osteotomy wedge height and a hinge position close to the medial cortex. Furthermore, dislocation of a medial hinge fracture > 2 mm was associated with malunion and should, therefore, be avoided. Level of evidence Prognostic study; Level IV.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.